Psyllid ID: psy11022


Local Sequence Feature Prediction

Prediction and (Method)Result
Residue Number Marker
Protein Sequence ?
Secondary Structure (PSIPRED) ?
Secondary Structure Prediction (SSPRO) ?
Coil and Loop (DISEMBL) ?
Flexible Loop (DISEMBL) ?
Low Complexity Region (SEG) ?
Disordered region (IsUnstruct) ?
Disordered Region (DISOPRED) ?
Disordered Region (DISEMBL) ?
Disordered Region (DISPRO) ?
Transmembrane Helix (TMHMM) ?
Transmembrane Helix (HMMTOP) ?
Transmembrane Helix (MEMSAT) ?
TM Helix, Signal Peptide (MEMSAT_SVM) ?
TM Helix, Signal Peptide (Phobius) ?
Signal Peptide (SignalP HMM Mode) ?
Signal Peptide (SignalP NN Mode) ?
Coiled Coils (COILS) ?
Positional Conservation ?
 
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490--
MMTPDFSSNNSLFPFTTELLTSATPMDTVDPSTLPYDWNRVARLLITTGLSVLGSVGNGYMISSVMIEDHLRRRGNTYIAVEALADLLVSGVVIPVSAVMILAGIKQAEPIKEIMCHVQWFLTLLCSLVTVWTLAMIAMENYVRLCMPPECYTFFSKSHIILSVIMIWLVSILLTTLQFIYKVGPDYCSKKVSYMELYQGIIGSLFFFIPIIITCILYMKITYKVRLARQNPSFKPPVIFGWDYSLMLTNMYSYIMFIVLWIPFCIVMSVASFRHQITPSFYYLAWLALSKSCINSVLYCISNRHFRNAYINLFHYCCCKTTVTFSRRSRGDATRPSGDVRVHIIPGYNMYSYTSPQRGRDASKRTSSPYRSIIHITGNTYIAVEALADLLVSGVVIPVSAVMILAGIKQAEPIKEIMCHVQWFLTLLCSLVTVWTLAMIAMENYVRLCMPPECYTFFSKSHIILSVIMIWLVSILLTTLQFEKSIYSRSLT
cccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHccccEEEEEEEEcccccccHHHHHHHHHHHHHHHHHcccHHHHHHHHHcccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHcEEEEEccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccHHHEHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccHHHHHHHHHHHHHHHHHccHHHHHHHHHHHHcccccHHHHHHHHHHHHHcHHHHHHHHHccHHHHHHHHHHHccccccccccccccccccccccccccEEEEccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHccccHHHHHHHHHcccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHcEEEEcccccccccccHHHHHHHHHHHHHHHHHHHHHcccccEEccccc
cccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHEEEEcccccccccccHHHHHHHHHHHHHHHHHHHccHHHcccccccccccEcccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccHHHHHHHHHHHHHHHcHHHHHHHcHHHHHHHHHHHHHcccccccccccccccccccccccccEEEccccccccccccccccccccccccccccccccccccccHHHHHEEcccccccccccEcccccccccEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccEEHccHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccc
mmtpdfssnnslfpfttelltsatpmdtvdpstlpydwNRVARLLITTGLSvlgsvgngymiSSVMIEDHLRRRGNTYIAVEALADLLVSGVVIPVSAVMILAGIKQAEPIKEIMCHVQWFLTLLCSLVTVWTLAMIAMENYVrlcmppecytffsKSHIILSVIMIWLVSILLTTLQFIYKVgpdycskkVSYMELYQGIIGSLFFFIPIIITCILYMKITYKVRLarqnpsfkppvifgWDYSLMLTNMYSYIMFIVLWIPFCIVMSvasfrhqitpSFYYLAWLALSKSCINSVLYCISNRHFRNAYINLFHYCCckttvtfsrrsrgdatrpsgdvrvhiipgynmysytspqrgrdaskrtsspyrsiihiTGNTYIAVEALADLLVSGVVIPVSAVMILAGIKQAEPIKEIMCHVQWFLTLLCSLVTVWTLAMIAMENYVrlcmppecytffsKSHIILSVIMIWLVSILLTTLQFEKSIYSRSLT
mmtpdfssnnslFPFTTELLTSATPMDTVDPSTLPYDWNRVARLLITTGLSVLGSVGNGYMISSVMIEDHLRRRGNTYIAVEALADLLVSGVVIPVSAVMILAGIKQAEPIKEIMCHVQWFLTLLCSLVTVWTLAMIAMENYVRLCMPPECYTFFSKSHIILSVIMIWLVSILLTTLQFIYKVGPDYCSKKVSYMELYQGIIGSLFFFIPIIITCILYMKITYKVRLarqnpsfkppVIFGWDYSLMLTNMYSYIMFIVLWIPFCIVMSVASFRHQITPSFYYLAWLALSKSCINSVLYCISNRHFRNAYINLFHYCCCKTTVtfsrrsrgdatrpsgdvrvhiipgynmysytspqrgrdaskRTSSPYRSIIHITGNTYIAVEALADLLVSGVVIPVSAVMILAGIKQAEPIKEIMCHVQWFLTLLCSLVTVWTLAMIAMENYVRLCMPPECYTFFSKSHIILSVIMIWLVSILLTTLqfeksiysrslt
MMTPDFSSNNSLFPFTTELLTSATPMDTVDPSTLPYDWNRVARLLITTGLSVLGSVGNGYMISSVMIEDHLRRRGNTYIAVEALADLLVSGVVIPVSAVMILAGIKQAEPIKEIMCHVQWFLTLLCSLVTVWTLAMIAMENYVRLCMPPECYTFFSKSHIILSVIMIWLVSILLTTLQFIYKVGPDYCSKKVSYMELYQGIIGSLFFFIPIIITCILYMKITYKVRLARQNPSFKPPVIFGWDYSLMLTNMYSYIMFIVLWIPFCIVMSVASFRHQITPSFYYLAWLALSKSCINSVLYCISNRHFRNAYINLFHYCCCKTTVTFSRRSRGDATRPSGDVRVHIIPGYNMYSYTSPQRGRDASKRTSSPYRSIIHITGNTYIAVEALADLLVSGVVIPVSAVMILAGIKQAEPIKEIMCHVQWFLTLLCSLVTVWTLAMIAMENYVRLCMPPECYTFFSKSHIILSVIMIWLVSILLTTLQFEKSIYSRSLT
************FPFTTELLTSATPMDTVDPSTLPYDWNRVARLLITTGLSVLGSVGNGYMISSVMIEDHLRRRGNTYIAVEALADLLVSGVVIPVSAVMILAGIKQAEPIKEIMCHVQWFLTLLCSLVTVWTLAMIAMENYVRLCMPPECYTFFSKSHIILSVIMIWLVSILLTTLQFIYKVGPDYCSKKVSYMELYQGIIGSLFFFIPIIITCILYMKITYKVRLARQNPSFKPPVIFGWDYSLMLTNMYSYIMFIVLWIPFCIVMSVASFRHQITPSFYYLAWLALSKSCINSVLYCISNRHFRNAYINLFHYCCCKTTVTFSR***********DVRVHIIPGYNMYSY****************YRSIIHITGNTYIAVEALADLLVSGVVIPVSAVMILAGIKQAEPIKEIMCHVQWFLTLLCSLVTVWTLAMIAMENYVRLCMPPECYTFFSKSHIILSVIMIWLVSILLTTLQFEKSIY*****
***********LFPFTTELLTSATPMDTVDPSTLPYDWNRVARLLITTGLSVLGSVGNGYMISSVMIEDHLRRRGNTYIAVEALADLLVSGVVIPVSAVMILAGIKQAEPIKEIMCHVQWFLTLLCSLVTVWTLAMIAMENYVRLCMPPECYTFFSKSHIILSVIMIWLVSILLTTLQFIYKVGPDYCSKKVSYMELYQGIIGSLFFFIPIIITCILYMKITY************************LTNMYSYIMFIVLWIPFCIVMSVASFRHQITPSFYYLAWLALSKSCINSVLYCISNRHFRNAYINLFHYCC********************************************************HITGNTYIAVEALADLLVSGVVIPVSAVMILAGIKQAEPIKEIMCHVQWFLTLLCSLVTVWTLAMIAMENYVRLCMPPECYTFFSKSHIILSVIMIWLVSILLTTLQFEKSIYSRS**
********NNSLFPFTTELLTSATPMDTVDPSTLPYDWNRVARLLITTGLSVLGSVGNGYMISSVMIEDHLRRRGNTYIAVEALADLLVSGVVIPVSAVMILAGIKQAEPIKEIMCHVQWFLTLLCSLVTVWTLAMIAMENYVRLCMPPECYTFFSKSHIILSVIMIWLVSILLTTLQFIYKVGPDYCSKKVSYMELYQGIIGSLFFFIPIIITCILYMKITYKVRLARQNPSFKPPVIFGWDYSLMLTNMYSYIMFIVLWIPFCIVMSVASFRHQITPSFYYLAWLALSKSCINSVLYCISNRHFRNAYINLFHYCCCKTTVTF***********SGDVRVHIIPGYNMYSYT*************SPYRSIIHITGNTYIAVEALADLLVSGVVIPVSAVMILAGIKQAEPIKEIMCHVQWFLTLLCSLVTVWTLAMIAMENYVRLCMPPECYTFFSKSHIILSVIMIWLVSILLTTLQFEKSIYSRSLT
*******************************STLPYDWNRVARLLITTGLSVLGSVGNGYMISSVMIEDHLRRRGNTYIAVEALADLLVSGVVIPVSAVMILAGIKQAEPIKEIMCHVQWFLTLLCSLVTVWTLAMIAMENYVRLCMPPECYTFFSKSHIILSVIMIWLVSILLTTLQFIYKVGPDYCSKKVSYMELYQGIIGSLFFFIPIIITCILYMKITYKVRLARQNPSFKPPVIFGWDYSLMLTNMYSYIMFIVLWIPFCIVMSVASFRHQITPSFYYLAWLALSKSCINSVLYCISNRHFRNAYINLFHYCCCKT*********************************************************NTYIAVEALADLLVSGVVIPVSAVMILAGIKQAEPIKEIMCHVQWFLTLLCSLVTVWTLAMIAMENYVRLCMPPECYTFFSKSHIILSVIMIWLVSILLTTLQFEKSIYS****
oooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooo
oooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiii
oooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHoooooooo
oooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiii
ooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHoooooHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHoooooHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHiiiiiiiiii
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
MMTPDFSSNNSLFPFTTELLTSATPMDTVDPSTLPYDWNRVARLLITTGLSVLGSVGNGYMISSVMIEDHLRRRGNTYIAVEALADLLVSGVVIPVSAVMILAGIKQAEPIKEIMCHVQWFLTLLCSLVTVWTLAMIAMENYVRLCMPPECYTFFSKSHIILSVIMIWLVSILLTTLQFIYKVGPDYCSKKVSYMELYQGIIGSLFFFIPIIITCILYMKITYKVRLARQNPSFKPPVIFGWDYSLMLTNMYSYIMFIVLWIPFCIVMSVASFRHQITPSFYYLAWLALSKSCINSVLYCISNRHFRNAYINLFHYCCCKTTVTFSRRSRGDATRPSGDVRVHIIPGYNMYSYTSPQRGRDASKRTSSPYRSIIHITGNTYIAVEALADLLVSGVVIPVSAVMILAGIKQAEPIKEIMCHVQWFLTLLCSLVTVWTLAMIAMENYVRLCMPPECYTFFSKSHIILSVIMIWLVSILLTTLQFEKSIYSRSLT
no confident homologs detected

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST ?

ID ?Alignment graph ?Length ? Definition ? RBH(Q2H) ? RBH(H2Q) ? Q cover ? H cover ? Identity ? E-value ?
Query492 2.2.26 [Sep-21-2011]
P97292358 Histamine H2 receptor OS= yes N/A 0.510 0.701 0.253 5e-14
P49286362 Melatonin receptor type 1 yes N/A 0.524 0.712 0.255 5e-13
P43140466 Alpha-1A adrenergic recep yes N/A 0.550 0.581 0.214 1e-12
P43141428 Beta-4C adrenergic recept no N/A 0.518 0.595 0.236 1e-12
P18130466 Alpha-1A adrenergic recep yes N/A 0.550 0.581 0.217 1e-12
P48039350 Melatonin receptor type 1 no N/A 0.548 0.771 0.241 3e-12
P47747359 Histamine H2 receptor OS= yes N/A 0.514 0.704 0.247 5e-12
P25102358 Histamine H2 receptor OS= no N/A 0.579 0.796 0.251 5e-12
Q61184353 Melatonin receptor type 1 no N/A 0.558 0.779 0.249 5e-12
P51049347 Melatonin receptor type 1 no N/A 0.577 0.818 0.230 7e-12
>sp|P97292|HRH2_MOUSE Histamine H2 receptor OS=Mus musculus GN=Hrh2 PE=2 SV=1 Back     alignment and function desciption
 Score = 79.7 bits (195), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 127/284 (44%), Gaps = 33/284 (11%)

Query: 57  GNGYMISSVMIEDHLRRRGNTYIAVEALADLLVSGVVIPVSAVMILAGIKQAEPIKEIMC 116
           GN  +  +V +   LR   N +I   A  DLL+  +V+P SA+  L+   +     ++ C
Sbjct: 35  GNVVVCLAVSLNRRLRSLTNCFIVSLAATDLLLGLLVMPFSAIYQLSFKWR---FGQVFC 91

Query: 117 HVQWFLTLLCSLVTVWTLAMIAMENYVRLCMPPECYTFFSKSHIILSVIMIWLVSILLTT 176
           ++   L ++    ++  L MI+++ Y  +  P       +   + +S++ IW++SI L+ 
Sbjct: 92  NIYTSLDVMLCTASILNLFMISLDRYCAVTDPLRYPVLVTPVRVAISLVFIWVISITLSF 151

Query: 177 LQFIY--------KVGPDYCSKKVSYMELYQGIIGSLFFFIPIIITCILYMKITYKVRLA 228
           L            + G D    KV   E+Y  + G + F++P++I C+ Y +I    ++A
Sbjct: 152 LSIHLGWNSRNGTRGGNDTFKCKVQVNEVYGLVDGMVTFYLPLLIMCVTYYRI---FKIA 208

Query: 229 RQNP-------SFKPPVIFGWDYSLMLTNMYSYIMFIVLWIPFCIVMSVASFR-----HQ 276
           R+         S+K   I     ++ L  +     FIV W P+         R     ++
Sbjct: 209 REQAKRINHISSWKAATIREHKATVTLAAVMG--AFIVCWFPYFTAFVYRGLRGDDPVNE 266

Query: 277 ITPSFYYLAWLALSKSCINSVLYCISNRHFRNAYINLFHYCCCK 320
           +      + WL  + S +N +LY   NR FR AY  LFH   CK
Sbjct: 267 VVEGI--VLWLGYANSALNPILYATLNRDFRMAYQQLFH---CK 305




The H2 subclass of histamine receptors mediates gastric acid secretion. The activity of this receptor is mediated by G proteins which activate adenylyl cyclase.
Mus musculus (taxid: 10090)
>sp|P49286|MTR1B_HUMAN Melatonin receptor type 1B OS=Homo sapiens GN=MTNR1B PE=2 SV=1 Back     alignment and function description
>sp|P43140|ADA1A_RAT Alpha-1A adrenergic receptor OS=Rattus norvegicus GN=Adra1a PE=2 SV=1 Back     alignment and function description
>sp|P43141|ADB4C_MELGA Beta-4C adrenergic receptor OS=Meleagris gallopavo GN=ADRB4C PE=2 SV=1 Back     alignment and function description
>sp|P18130|ADA1A_BOVIN Alpha-1A adrenergic receptor OS=Bos taurus GN=ADRA1A PE=2 SV=1 Back     alignment and function description
>sp|P48039|MTR1A_HUMAN Melatonin receptor type 1A OS=Homo sapiens GN=MTNR1A PE=2 SV=1 Back     alignment and function description
>sp|P47747|HRH2_CAVPO Histamine H2 receptor OS=Cavia porcellus GN=HRH2 PE=3 SV=1 Back     alignment and function description
>sp|P25102|HRH2_RAT Histamine H2 receptor OS=Rattus norvegicus GN=Hrh2 PE=2 SV=1 Back     alignment and function description
>sp|Q61184|MTR1A_MOUSE Melatonin receptor type 1A OS=Mus musculus GN=Mtnr1a PE=2 SV=1 Back     alignment and function description
>sp|P51049|MR1BB_DANRE Melatonin receptor type 1B-B OS=Danio rerio GN=mtnr1bb PE=2 SV=2 Back     alignment and function description

Close Homologs in the Non-Redundant Database Detected by BLAST ?

GI ?Alignment Graph ?Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query492
328701295403 PREDICTED: alpha-1A adrenergic receptor- 0.678 0.828 0.607 1e-122
189235262 3197 PREDICTED: similar to AGAP005356-PA [Tri 0.703 0.108 0.538 1e-114
270004135359 hypothetical protein TcasGA2_TC003453 [T 0.703 0.963 0.538 1e-107
242020744388 G-protein coupled octopamine receptor, p 0.715 0.907 0.526 1e-101
340715965376 PREDICTED: neuropeptide Y receptor-like 0.672 0.880 0.488 2e-89
350419966376 PREDICTED: neuropeptide Y receptor-like 0.664 0.869 0.489 3e-89
383860183359 PREDICTED: neuropeptide Y receptor-like 0.666 0.913 0.492 3e-87
328776745356 PREDICTED: neuropeptide Y receptor-like 0.668 0.924 0.473 1e-82
345484578395 PREDICTED: alpha-1B adrenergic receptor- 0.668 0.832 0.460 3e-81
158294045456 AGAP005356-PA [Anopheles gambiae str. PE 0.670 0.723 0.459 2e-77
>gi|328701295|ref|XP_001946275.2| PREDICTED: alpha-1A adrenergic receptor-like [Acyrthosiphon pisum] Back     alignment and taxonomy information
 Score =  446 bits (1146), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 206/339 (60%), Positives = 259/339 (76%), Gaps = 5/339 (1%)

Query: 27  DTVDPSTLPYDWNRVARLLITTGLSVLGSVGNGYMISSVMIEDHLRRRGNTYIAVEALAD 86
           D V P TL  +W+RVARLLI  GLSV+GS+GN YMISSVMIEDHL +RGNT++A  ALAD
Sbjct: 31  DAVSPVTLSMEWSRVARLLIMIGLSVIGSIGNVYMISSVMIEDHLNKRGNTFVANVALAD 90

Query: 87  LLVSGVVIPVSAVMILAGIKQAEPIKEIMCHVQWFLTLLCSLVTVWTLAMIAMENYVRLC 146
           LL+SG+VIP SAV+IL+G++ + P+    C  QWFL++LC LVTV T+A +A ENY+RLC
Sbjct: 91  LLISGLVIPASAVVILSGLQDSPPV----CQFQWFLSILCCLVTVLTMAAVAAENYIRLC 146

Query: 147 MPPECYTFFSKSHIILSVIMIWLVSILLTTLQFIYKVGPDYCSKKVSYMELYQGIIGSLF 206
           + PECY   + + I   +  IW++S +L TLQ +Y +GPDYC+KK+S +   Q +     
Sbjct: 147 LTPECYAKLTVTKITTLLFAIWIISSILVTLQSVYNMGPDYCNKKISRIVPTQALTAGAI 206

Query: 207 FFIPIIITCILYMKITYKVRLARQNPSFKPPVIFGWDYSLMLTNMYSYIMFIVLWIPFCI 266
              P++IT  LYM+ITY+V +AR NPSFKPP+ F WDYSLML N YS++MF+V W PF I
Sbjct: 207 VLAPLLITAGLYMRITYQVHVARLNPSFKPPLAFNWDYSLMLANAYSFVMFVVFWAPFTI 266

Query: 267 VMSVASF-RHQITPSFYYLAWLALSKSCINSVLYCISNRHFRNAYINLFHYCCCKTTVTF 325
           V+++A+  R Q    FY LAWLALSKSC N+++YC  NRHFRNAY+NLFHYCCCKTTVTF
Sbjct: 267 VLALATIQRQQSAQVFYNLAWLALSKSCFNNLVYCAGNRHFRNAYVNLFHYCCCKTTVTF 326

Query: 326 SRRSRGDATRPSGDVRVHIIPGYNMYSYTSPQRGRDASK 364
           SRR+R  ATRPSGDVRVHIIPGYNMYSYTSP R R++  
Sbjct: 327 SRRARDGATRPSGDVRVHIIPGYNMYSYTSPTRSRESGS 365




Source: Acyrthosiphon pisum

Species: Acyrthosiphon pisum

Genus: Acyrthosiphon

Family: Aphididae

Order: Hemiptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|189235262|ref|XP_001814462.1| PREDICTED: similar to AGAP005356-PA [Tribolium castaneum] Back     alignment and taxonomy information
>gi|270004135|gb|EFA00583.1| hypothetical protein TcasGA2_TC003453 [Tribolium castaneum] Back     alignment and taxonomy information
>gi|242020744|ref|XP_002430811.1| G-protein coupled octopamine receptor, putative [Pediculus humanus corporis] gi|212516014|gb|EEB18073.1| G-protein coupled octopamine receptor, putative [Pediculus humanus corporis] Back     alignment and taxonomy information
>gi|340715965|ref|XP_003396476.1| PREDICTED: neuropeptide Y receptor-like [Bombus terrestris] Back     alignment and taxonomy information
>gi|350419966|ref|XP_003492355.1| PREDICTED: neuropeptide Y receptor-like [Bombus impatiens] Back     alignment and taxonomy information
>gi|383860183|ref|XP_003705570.1| PREDICTED: neuropeptide Y receptor-like [Megachile rotundata] Back     alignment and taxonomy information
>gi|328776745|ref|XP_393375.4| PREDICTED: neuropeptide Y receptor-like [Apis mellifera] Back     alignment and taxonomy information
>gi|345484578|ref|XP_003425076.1| PREDICTED: alpha-1B adrenergic receptor-like [Nasonia vitripennis] Back     alignment and taxonomy information
>gi|158294045|ref|XP_001688647.1| AGAP005356-PA [Anopheles gambiae str. PEST] gi|157015382|gb|EDO63653.1| AGAP005356-PA [Anopheles gambiae str. PEST] Back     alignment and taxonomy information

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST ?

ID ? Alignment graph ? Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query492
ZFIN|ZDB-GENE-990415-154347 mtnr1al "melatonin receptor ty 0.573 0.812 0.269 7.9e-19
UNIPROTKB|F1PK71461 ADRA1B "Alpha-1B adrenergic re 0.461 0.492 0.255 2.4e-18
UNIPROTKB|J9PBA4509 ADRA1B "Alpha-1B adrenergic re 0.461 0.445 0.255 3.6e-18
UNIPROTKB|P18841515 ADRA1B "Alpha-1B adrenergic re 0.461 0.440 0.255 3.7e-18
UNIPROTKB|F1RR36518 ADRA1B "Uncharacterized protei 0.461 0.438 0.255 3.8e-18
UNIPROTKB|P35368520 ADRA1B "Alpha-1B adrenergic re 0.461 0.436 0.255 3.9e-18
RGD|2054515 Adra1b "adrenoceptor alpha 1B" 0.414 0.396 0.254 2.8e-17
UNIPROTKB|F1NIZ5376 ADRA1B "Uncharacterized protei 0.402 0.526 0.246 4.1e-17
RGD|2831358 Hrh2 "histamine receptor H 2" 0.581 0.798 0.255 4.4e-17
UNIPROTKB|P25102358 Hrh2 "Histamine H2 receptor" [ 0.581 0.798 0.255 4.4e-17
ZFIN|ZDB-GENE-990415-154 mtnr1al "melatonin receptor type 1A like" [Danio rerio (taxid:7955)] Back     alignment and assigned GO terms
 Score = 244 (91.0 bits), Expect = 7.9e-19, P = 7.9e-19
 Identities = 83/308 (26%), Positives = 145/308 (47%)

Query:    30 DPSTLPYDW--NRVARLLITTGLSVLGSVGNGYMISSVMIEDHLRRRGNTYIAVEALADL 87
             D   L + W    ++ +LITT   V+  +GN  +I SV     LR+ GN ++   A+ADL
Sbjct:    47 DIKYLSFPWVVTLLSSVLITT--IVVDVLGNLLVIVSVFRNRKLRKAGNAFVVSLAIADL 104

Query:    88 LVSGVVIPVSAVMILAGIKQAEPIK-EIMCHVQWFLTLLCSLVTVWTLAMIAMENYVRLC 146
             LV+  + P    ++L  I     I  +I C +  FL  L  + +++ +  IA+  Y  +C
Sbjct:   105 LVA--IYPYP--LVLTAIFHDRWIAGDIHCQISGFLMGLSVIGSIFNITGIAINRYCYIC 160

Query:   147 MPPECYTFFSKSHIILSVIMIWLVSIL-LTTLQFIYKVGPD----YCSKKVSYMELYQGI 201
                +    FS  + +  VI++W +++L +    F+  +  D     C+   S   LY  +
Sbjct:   161 HSLKYDKLFSNKNTVCYVILVWALTVLAIVPNWFVESLQYDPRVFSCTFAQSVSSLYTIM 220

Query:   202 IGSLFFFIPIIITCILYMKITYKVRLARQN--PSFKPPVIFGWDYSLMLTNMYSYIMFIV 259
             +  + F +PI I    Y++I   V   R+   P  +P  I   D+   LT    +++F V
Sbjct:   221 VVVVHFIVPIGIVTYCYLRIWILVIQVRRRVKPDSRPK-IKPHDFRNFLTMFVVFVLFAV 279

Query:   260 LWIPFCIV-MSVASFRH--QITPSFYYLA--WLALSKSCINSVLYCISNRHFRNAY---- 310
              W P   + ++VA      Q  P + + A  ++A   SC+N V+Y + N +FR  Y    
Sbjct:   280 CWAPLNFIGLAVAIHPRLGQSIPEWLFTASYFMAYFNSCLNGVIYGVLNHNFRKEYKRIV 339

Query:   311 INLFHYCC 318
             + +F + C
Sbjct:   340 LAIFKFNC 347




GO:0007186 "G-protein coupled receptor signaling pathway" evidence=IEA
GO:0016021 "integral to membrane" evidence=IEA
GO:0004930 "G-protein coupled receptor activity" evidence=IEA
GO:0008502 "melatonin receptor activity" evidence=IEA
GO:0048511 "rhythmic process" evidence=IEA
GO:0005886 "plasma membrane" evidence=IEA
GO:0016020 "membrane" evidence=IEA
GO:0004871 "signal transducer activity" evidence=IEA
GO:0007165 "signal transduction" evidence=IEA
UNIPROTKB|F1PK71 ADRA1B "Alpha-1B adrenergic receptor" [Canis lupus familiaris (taxid:9615)] Back     alignment and assigned GO terms
UNIPROTKB|J9PBA4 ADRA1B "Alpha-1B adrenergic receptor" [Canis lupus familiaris (taxid:9615)] Back     alignment and assigned GO terms
UNIPROTKB|P18841 ADRA1B "Alpha-1B adrenergic receptor" [Mesocricetus auratus (taxid:10036)] Back     alignment and assigned GO terms
UNIPROTKB|F1RR36 ADRA1B "Uncharacterized protein" [Sus scrofa (taxid:9823)] Back     alignment and assigned GO terms
UNIPROTKB|P35368 ADRA1B "Alpha-1B adrenergic receptor" [Homo sapiens (taxid:9606)] Back     alignment and assigned GO terms
RGD|2054 Adra1b "adrenoceptor alpha 1B" [Rattus norvegicus (taxid:10116)] Back     alignment and assigned GO terms
UNIPROTKB|F1NIZ5 ADRA1B "Uncharacterized protein" [Gallus gallus (taxid:9031)] Back     alignment and assigned GO terms
RGD|2831 Hrh2 "histamine receptor H 2" [Rattus norvegicus (taxid:10116)] Back     alignment and assigned GO terms
UNIPROTKB|P25102 Hrh2 "Histamine H2 receptor" [Rattus norvegicus (taxid:10116)] Back     alignment and assigned GO terms

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries ?

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by EFICAz Software ?

No EC number assignment, probably not an enzyme!


Prediction of Functionally Associated Proteins


Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query492
pfam00001251 pfam00001, 7tm_1, 7 transmembrane receptor (rhodop 9e-18
pfam00001 251 pfam00001, 7tm_1, 7 transmembrane receptor (rhodop 3e-08
PHA02834323 PHA02834, PHA02834, chemokine receptor-like protei 0.001
>gnl|CDD|215646 pfam00001, 7tm_1, 7 transmembrane receptor (rhodopsin family) Back     alignment and domain information
 Score = 82.4 bits (204), Expect = 9e-18
 Identities = 45/247 (18%), Positives = 101/247 (40%), Gaps = 20/247 (8%)

Query: 70  HLRRRGNTYIAVEALADLLVSGVVIPVSAVMILAGIKQAEPIKEIMCHVQWFLTLLCSLV 129
            LR   N ++   A+ADLL    + P +   ++ G     P  + +C +  FL ++    
Sbjct: 8   KLRTPTNIFLLNLAVADLLFLLTLPPWALYYLVGGDW---PFGDALCKLVGFLFVVNGYA 64

Query: 130 TVWTLAMIAMENYVRLCMPPECYTFFSKSHIILSVIMIWLVSILLTTLQFIY-------K 182
           ++  L  I+++ Y+ +  P       +     + ++++W++++LL+    ++       +
Sbjct: 65  SILLLTAISIDRYLAIVHPLRYRRIRTPRRAKVLILVVWVLALLLSLPPLLFSWLRTVEE 124

Query: 183 VGPDYCS---KKVSYMELYQGIIGSLFFFIPIIITCILYMKITYKVRLARQNPSFKPPVI 239
                C     + S    Y  +   L F +P+++  + Y  I   +R   ++ + +    
Sbjct: 125 GNVTTCLIDFPEESTKRSYTLLSTLLGFVLPLLVILVCYTLILRTLRKRARSGASQARAK 184

Query: 240 FGWDYSLMLTNMYSYIM--FIVLWIPFCIVMSVASFRHQITPSFYYLA-----WLALSKS 292
                      M   ++  F++ W+P+ IV+ + S            A     WLA   S
Sbjct: 185 RSSSKERKAAKMLLVVVVVFVLCWLPYHIVLLLDSLCPLSIWRLLPTALLITLWLAYVNS 244

Query: 293 CINSVLY 299
           C+N ++Y
Sbjct: 245 CLNPIIY 251


This family contains, amongst other G-protein-coupled receptors (GCPRs), members of the opsin family, which have been considered to be typical members of the rhodopsin superfamily. They share several motifs, mainly the seven transmembrane helices, GCPRs of the rhodopsin superfamily. All opsins bind a chromophore, such as 11-cis-retinal. The function of most opsins other than the photoisomerases is split into two steps: light absorption and G-protein activation. Photoisomerases, on the other hand, are not coupled to G-proteins - they are thought to generate and supply the chromophore that is used by visual opsins. Length = 251

>gnl|CDD|215646 pfam00001, 7tm_1, 7 transmembrane receptor (rhodopsin family) Back     alignment and domain information
>gnl|CDD|165177 PHA02834, PHA02834, chemokine receptor-like protein; Provisional Back     alignment and domain information

Conserved Domains Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query 492
KOG4219|consensus423 100.0
PHA03234338 DNA packaging protein UL33; Provisional 100.0
PHA03235409 DNA packaging protein UL33; Provisional 100.0
KOG4220|consensus503 100.0
PHA02638417 CC chemokine receptor-like protein; Provisional 100.0
PHA02834323 chemokine receptor-like protein; Provisional 100.0
PHA03087335 G protein-coupled chemokine receptor-like protein; 100.0
PF00001257 7tm_1: 7 transmembrane receptor (rhodopsin family) 99.97
KOG2087|consensus363 99.9
PF10320257 7TM_GPCR_Srsx: Serpentine type 7TM GPCR chemorecep 99.9
PF10324318 7TM_GPCR_Srw: Serpentine type 7TM GPCR chemorecept 99.83
KOG4219|consensus 423 99.77
PF10328274 7TM_GPCR_Srx: Serpentine type 7TM GPCR chemorecept 99.77
KOG4220|consensus 503 99.71
PF10323283 7TM_GPCR_Srv: Serpentine type 7TM GPCR chemorecept 99.69
PHA03234 338 DNA packaging protein UL33; Provisional 99.62
PF05296303 TAS2R: Mammalian taste receptor protein (TAS2R); I 99.58
PF05462303 Dicty_CAR: Slime mold cyclic AMP receptor 99.55
PF10321313 7TM_GPCR_Srt: Serpentine type 7TM GPCR chemorecept 99.54
PHA02834 323 chemokine receptor-like protein; Provisional 99.54
PF00001 257 7tm_1: 7 transmembrane receptor (rhodopsin family) 99.52
PHA02638 417 CC chemokine receptor-like protein; Provisional 99.51
PHA03235 409 DNA packaging protein UL33; Provisional 99.44
PHA03087 335 G protein-coupled chemokine receptor-like protein; 99.42
PF03402265 V1R: Vomeronasal organ pheromone receptor family, 99.19
KOG2087|consensus 363 99.14
PF10317292 7TM_GPCR_Srd: Serpentine type 7TM GPCR chemorecept 99.06
PF11710201 Git3: G protein-coupled glucose receptor regulatin 98.86
PF10327303 7TM_GPCR_Sri: Serpentine type 7TM GPCR chemorecept 98.83
PF10292324 7TM_GPCR_Srab: Serpentine type 7TM GPCR receptor c 98.77
PF10326307 7TM_GPCR_Str: Serpentine type 7TM GPCR chemorecept 98.73
PF02101405 Ocular_alb: Ocular albinism type 1 protein; InterP 98.72
KOG4193|consensus610 98.65
PF10318302 7TM_GPCR_Srh: Serpentine type 7TM GPCR chemorecept 98.65
PF10320 257 7TM_GPCR_Srsx: Serpentine type 7TM GPCR chemorecep 98.62
PF02118275 Srg: Srg family chemoreceptor; InterPro: IPR000609 98.59
KOG4564|consensus473 98.42
PF10319310 7TM_GPCR_Srj: Serpentine type 7TM GPCR chemorecept 98.37
PF10328 274 7TM_GPCR_Srx: Serpentine type 7TM GPCR chemorecept 98.36
PF10316273 7TM_GPCR_Srbc: Serpentine type 7TM GPCR chemorecep 98.35
PF04789305 DUF621: Protein of unknown function (DUF621); Inte 98.24
PF00002242 7tm_2: 7 transmembrane receptor (Secretin family); 98.07
PF03125365 Sre: C. elegans Sre G protein-coupled chemorecepto 97.95
PF02117328 7TM_GPCR_Sra: Serpentine type 7TM GPCR chemorecept 97.93
PF11710201 Git3: G protein-coupled glucose receptor regulatin 97.4
PF10324 318 7TM_GPCR_Srw: Serpentine type 7TM GPCR chemorecept 97.39
PF10323 283 7TM_GPCR_Srv: Serpentine type 7TM GPCR chemorecept 97.34
PF10322307 7TM_GPCR_Sru: Serpentine type 7TM GPCR chemorecept 97.11
PF01534328 Frizzled: Frizzled/Smoothened family membrane regi 96.62
PF02076283 STE3: Pheromone A receptor; InterPro: IPR001499 G- 96.25
PF05462 303 Dicty_CAR: Slime mold cyclic AMP receptor 95.74
PF03383153 Serpentine_r_xa: Caenorhabditis serpentine recepto 95.58
PF03383153 Serpentine_r_xa: Caenorhabditis serpentine recepto 94.95
PF1197076 Git3_C: G protein-coupled glucose receptor regulat 94.9
PF06681226 DUF1182: Protein of unknown function (DUF1182); In 94.64
PF02175236 7TM_GPCR_Srb: Serpentine type 7TM GPCR chemorecept 94.5
KOG4289|consensus2531 90.7
PF10316 273 7TM_GPCR_Srbc: Serpentine type 7TM GPCR chemorecep 82.34
PF03402 265 V1R: Vomeronasal organ pheromone receptor family, 81.99
>KOG4219|consensus Back     alignment and domain information
Probab=100.00  E-value=6e-43  Score=322.51  Aligned_cols=281  Identities=20%  Similarity=0.382  Sum_probs=238.8

Q ss_pred             CCCcchHHHHHHHHHHHHHHHHhhhcceeeeeeeeccccccchhhHHHHHHHHHHHhhhchhcHHHHHHHhcCCCccccc
Q psy11022         33 TLPYDWNRVARLLITTGLSVLGSVGNGYMISSVMIEDHLRRRGNTYIAVEALADLLVSGVVIPVSAVMILAGIKQAEPIK  112 (492)
Q Consensus        33 ~~~~~~~~~~~~~~~~~~~i~gl~gN~~vi~~i~~~~~lr~~~~~~l~~Lai~Dll~~~~~~p~~~~~~~~~~~~~~~~~  112 (492)
                      ...+.+...+.++++.++.+++++||+++++++..+|++|+.+|+|++|||+||++++++..++.......+   +|.+|
T Consensus        28 f~lp~~~~~~wai~yg~l~~vAv~GN~iVlwIil~hrrMRtvtnyfL~NLAfADl~~s~Fn~~f~f~yal~~---~W~~G  104 (423)
T KOG4219|consen   28 FVLPAWQQALWAIAYGLLVFVAVVGNLIVLWIILAHRRMRTVTNYFLVNLAFADLSMSIFNTVFNFQYALHQ---EWYFG  104 (423)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHhcCceEEEEEeehhehhhhHHHHHHHHHHHHHHHHHHhhHHHHHHHHHh---ccccc
Confidence            345667788899999999999999999999999999999999999999999999999999999988877775   59999


Q ss_pred             cccchhhHHHHHHHHHHHHHHHHHHHHHHHHHHhcCcccccccchhhHHhHhhHHHHHHHHHhhhhhhhcc---------
Q psy11022        113 EIMCHVQWFLTLLCSLVTVWTLAMIAMENYVRLCMPPECYTFFSKSHIILSVIMIWLVSILLTTLQFIYKV---------  183 (492)
Q Consensus       113 ~~~C~~~~~~~~~~~~~s~~~l~~ia~dRy~aI~~P~~~~~~~t~~~~~~~i~~~w~~s~~~~~~~~~~~~---------  183 (492)
                      .+.|++..|+......+|++++++||+|||.||.||++.+  .++|.++..++++|+.++++++|..++..         
T Consensus       105 ~f~C~f~nf~~itav~vSVfTlvAiA~DRy~AIi~Pl~~r--~s~r~sk~iIllIW~lA~l~a~P~~l~s~v~~~~~~d~  182 (423)
T KOG4219|consen  105 SFYCRFVNFFPITAVFVSVFTLVAIAIDRYMAIIHPLQPR--PSRRSSKIIILLIWALALLLALPQLLYSSVEELYLYDG  182 (423)
T ss_pred             cceeeeccccchhhhhHhHHHHHHHHHHHHHHHhhhcccC--CCCcceeehhHHHHHHHHHHhccceeeeeeEEeeccCC
Confidence            9999999999999999999999999999999999997654  89999999999999999999999877421         


Q ss_pred             -cccccccccccc-----------hhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhcCCCCCC--CcccchhhHHHHH
Q psy11022        184 -GPDYCSKKVSYM-----------ELYQGIIGSLFFFIPIIITCILYMKITYKVRLARQNPSFKP--PVIFGWDYSLMLT  249 (492)
Q Consensus       184 -~~~~C~~~~~~~-----------~~~~~~~~~~~~~ip~~ii~~~y~~i~~~l~~~~~~~~~~~--~~~~~~~~~~~~~  249 (492)
                       ....|...++..           ..|.....++.+++|++++...|.+|.+++++.+..+.+..  .++.+.++|+.|+
T Consensus       183 ~~~~~~~~~~pe~~~~~~~~~~~~~~y~~vl~~lqYflPliVl~~~Yt~iav~LW~~~~~gd~~d~~~~~~kak~K~vkm  262 (423)
T KOG4219|consen  183 ESRVVCVTAWPEHVCPTENESLLMQGYNYVLLFLQYFLPLIVLGLAYTVIAVTLWGRRIPGDQQDRKHEQLKAKKKVVKM  262 (423)
T ss_pred             cceEEEEEecccccCCcchhhhhhcceeeeehhHHHHHHHHHHHHHHHHHHHHHHhccCccchhchhhHHHHHHHHHHHH
Confidence             122344443221           22666677899999999999999999999998764333222  3445668899999


Q ss_pred             HHHHHHHHHHHhHhHHHHHHHHhccCC------cchHHHHHHHHHhhcccccchhhhhcChHHHHHHHHHhcccc
Q psy11022        250 NMYSYIMFIVLWIPFCIVMSVASFRHQ------ITPSFYYLAWLALSKSCINSVLYCISNRHFRNAYINLFHYCC  318 (492)
Q Consensus       250 ~~~~~~~f~i~~~P~~i~~~~~~~~~~------~~~~~~~~~~l~~~~s~~nP~IY~~~~~~~R~~~~~~~~~~~  318 (492)
                      ++++++.|.+||+|+.+..++....+.      ...++....||++.|++.||+||++.|++||..+++.|++|.
T Consensus       263 liiVV~~FaicWlPyh~y~il~~~~~~i~~~k~i~~vyl~~~WLaMSst~yNPiIY~~lN~Rfr~gf~~~fr~cp  337 (423)
T KOG4219|consen  263 LIIVVVIFAICWLPYHIYFILNATNPEINRKKFIQQVYLAIYWLAMSSTCYNPIIYCFLNKRFRGGFRRAFRWCP  337 (423)
T ss_pred             HHHHHHHHHHhccChhHHHHHHHhHHHHHHHHHHHHHHHHHHHHHHHHhhhccHhhhhhHHHHHHHHhhhhheee
Confidence            999999999999999999998876332      334445567999999999999999999999999999998664



>PHA03234 DNA packaging protein UL33; Provisional Back     alignment and domain information
>PHA03235 DNA packaging protein UL33; Provisional Back     alignment and domain information
>KOG4220|consensus Back     alignment and domain information
>PHA02638 CC chemokine receptor-like protein; Provisional Back     alignment and domain information
>PHA02834 chemokine receptor-like protein; Provisional Back     alignment and domain information
>PHA03087 G protein-coupled chemokine receptor-like protein; Provisional Back     alignment and domain information
>PF00001 7tm_1: 7 transmembrane receptor (rhodopsin family) Rhodopsin-like GPCR superfamily signature 5-hydroxytryptamine 7 receptor signature bradykinin receptor signature gastrin receptor signature melatonin receptor signature olfactory receptor signature; InterPro: IPR000276 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>KOG2087|consensus Back     alignment and domain information
>PF10320 7TM_GPCR_Srsx: Serpentine type 7TM GPCR chemoreceptor Srsx; InterPro: IPR019424 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF10324 7TM_GPCR_Srw: Serpentine type 7TM GPCR chemoreceptor Srw; InterPro: IPR019427 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>KOG4219|consensus Back     alignment and domain information
>PF10328 7TM_GPCR_Srx: Serpentine type 7TM GPCR chemoreceptor Srx; InterPro: IPR019430 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>KOG4220|consensus Back     alignment and domain information
>PF10323 7TM_GPCR_Srv: Serpentine type 7TM GPCR chemoreceptor Srv; InterPro: IPR019426 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PHA03234 DNA packaging protein UL33; Provisional Back     alignment and domain information
>PF05296 TAS2R: Mammalian taste receptor protein (TAS2R); InterPro: IPR007960 This family consists of several forms of mammalian taste receptor proteins (TAS2Rs) Back     alignment and domain information
>PF05462 Dicty_CAR: Slime mold cyclic AMP receptor Back     alignment and domain information
>PF10321 7TM_GPCR_Srt: Serpentine type 7TM GPCR chemoreceptor Srt; InterPro: IPR019425 Chemoreception is mediated in Caenorhabditis elegans by members of the seven-transmembrane G-protein-coupled receptor class (7TM GPCRs) of proteins which are of the serpentine type [] Back     alignment and domain information
>PHA02834 chemokine receptor-like protein; Provisional Back     alignment and domain information
>PF00001 7tm_1: 7 transmembrane receptor (rhodopsin family) Rhodopsin-like GPCR superfamily signature 5-hydroxytryptamine 7 receptor signature bradykinin receptor signature gastrin receptor signature melatonin receptor signature olfactory receptor signature; InterPro: IPR000276 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PHA02638 CC chemokine receptor-like protein; Provisional Back     alignment and domain information
>PHA03235 DNA packaging protein UL33; Provisional Back     alignment and domain information
>PHA03087 G protein-coupled chemokine receptor-like protein; Provisional Back     alignment and domain information
>PF03402 V1R: Vomeronasal organ pheromone receptor family, V1R; InterPro: IPR004072 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>KOG2087|consensus Back     alignment and domain information
>PF10317 7TM_GPCR_Srd: Serpentine type 7TM GPCR chemoreceptor Srd; InterPro: IPR019421 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF11710 Git3: G protein-coupled glucose receptor regulating Gpa2; InterPro: IPR023041 This entry contains a functionally uncharacterised region belonging to the Git3 G-protein coupled receptor Back     alignment and domain information
>PF10327 7TM_GPCR_Sri: Serpentine type 7TM GPCR chemoreceptor Sri; InterPro: IPR019429 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF10292 7TM_GPCR_Srab: Serpentine type 7TM GPCR receptor class ab chemoreceptor; InterPro: IPR019408 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF10326 7TM_GPCR_Str: Serpentine type 7TM GPCR chemoreceptor Str; InterPro: IPR019428 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF02101 Ocular_alb: Ocular albinism type 1 protein; InterPro: IPR001414 Ocular albinism type 1 (OA1) is an X-linked disorder characterised by severe impairment of visual acuity, retinal hypopigmentation and the presence of macromelanosomes Back     alignment and domain information
>KOG4193|consensus Back     alignment and domain information
>PF10318 7TM_GPCR_Srh: Serpentine type 7TM GPCR chemoreceptor Srh; InterPro: IPR019422 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF10320 7TM_GPCR_Srsx: Serpentine type 7TM GPCR chemoreceptor Srsx; InterPro: IPR019424 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF02118 Srg: Srg family chemoreceptor; InterPro: IPR000609 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>KOG4564|consensus Back     alignment and domain information
>PF10319 7TM_GPCR_Srj: Serpentine type 7TM GPCR chemoreceptor Srj; InterPro: IPR019423 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF10328 7TM_GPCR_Srx: Serpentine type 7TM GPCR chemoreceptor Srx; InterPro: IPR019430 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF10316 7TM_GPCR_Srbc: Serpentine type 7TM GPCR chemoreceptor Srbc ; InterPro: IPR019420 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF04789 DUF621: Protein of unknown function (DUF621); InterPro: IPR006874 This is a conserved region found in uncharacterised proteins from Caenorhabditis elegans, and is noted to have possible G-protein-coupled receptor-like activity Back     alignment and domain information
>PF00002 7tm_2: 7 transmembrane receptor (Secretin family); InterPro: IPR000832 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF03125 Sre: C Back     alignment and domain information
>PF02117 7TM_GPCR_Sra: Serpentine type 7TM GPCR chemoreceptor Sra; InterPro: IPR000344 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF11710 Git3: G protein-coupled glucose receptor regulating Gpa2; InterPro: IPR023041 This entry contains a functionally uncharacterised region belonging to the Git3 G-protein coupled receptor Back     alignment and domain information
>PF10324 7TM_GPCR_Srw: Serpentine type 7TM GPCR chemoreceptor Srw; InterPro: IPR019427 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF10323 7TM_GPCR_Srv: Serpentine type 7TM GPCR chemoreceptor Srv; InterPro: IPR019426 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF10322 7TM_GPCR_Sru: Serpentine type 7TM GPCR chemoreceptor Sru; InterPro: IPR003839 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF01534 Frizzled: Frizzled/Smoothened family membrane region; InterPro: IPR000539 The frizzled (fz) locus of Drosophila coordinates the cytoskeletons of epidermal cells, producing a parallel array of cuticular hairs and bristles [, ] Back     alignment and domain information
>PF02076 STE3: Pheromone A receptor; InterPro: IPR001499 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF05462 Dicty_CAR: Slime mold cyclic AMP receptor Back     alignment and domain information
>PF03383 Serpentine_r_xa: Caenorhabditis serpentine receptor-like protein, class xa; InterPro: IPR005047 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF03383 Serpentine_r_xa: Caenorhabditis serpentine receptor-like protein, class xa; InterPro: IPR005047 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF11970 Git3_C: G protein-coupled glucose receptor regulating Gpa2 C-term; InterPro: IPR022596 This entry contains a functionally uncharacterised region belonging to the Git3 G-protein coupled receptor Back     alignment and domain information
>PF06681 DUF1182: Protein of unknown function (DUF1182); InterPro: IPR010601 This family consists of several hypothetical proteins of around 360 residues in length and seems to be specific to Caenorhabditis elegans Back     alignment and domain information
>PF02175 7TM_GPCR_Srb: Serpentine type 7TM GPCR chemoreceptor Srb; InterPro: IPR002184 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>KOG4289|consensus Back     alignment and domain information
>PF10316 7TM_GPCR_Srbc: Serpentine type 7TM GPCR chemoreceptor Srbc ; InterPro: IPR019420 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF03402 V1R: Vomeronasal organ pheromone receptor family, V1R; InterPro: IPR004072 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information

Homologous Structure Templates

Structure Templates Detected by BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query492
2y00_B315 Turkey Beta1 Adrenergic Receptor With Stabilising M 1e-10
2vt4_A313 Turkey Beta1 Adrenergic Receptor With Stabilising M 1e-10
2x72_A349 Crystal Structure Of The Constitutively Active E113 5e-08
3oax_A349 Crystal Structure Of Bovine Rhodopsin With Beta-Ion 8e-08
1jfp_A348 Structure Of Bovine Rhodopsin (Dark Adapted) Length 8e-08
4a4m_A349 Crystal Structure Of The Light-Activated Constituti 1e-07
2j4y_A349 Crystal Structure Of A Rhodopsin Stabilizing Mutant 1e-07
3c9m_A348 Structure Of A Mutant Bovine Rhodopsin In Hexagonal 1e-07
4gbr_A309 N-terminal T4 Lysozyme Fusion Facilitates Crystalli 7e-06
3d4s_A490 Cholesterol Bound Form Of Human Beta2 Adrenergic Re 2e-05
3d4s_A 490 Cholesterol Bound Form Of Human Beta2 Adrenergic Re 3e-04
3pbl_A481 Structure Of The Human Dopamine D3 Receptor In Comp 5e-05
4djh_A480 Structure Of The Human Kappa Opioid Receptor In Com 3e-04
3sn6_R514 Crystal Structure Of The Beta2 Adrenergic Receptor- 3e-04
3kj6_A366 Crystal Structure Of A Methylated Beta2 Adrenergic 4e-04
2r4r_A365 Crystal Structure Of The Human Beta2 Adrenoceptor L 5e-04
2r4s_A342 Crystal Structure Of The Human Beta2 Adrenoceptor L 5e-04
2rh1_A500 High Resolution Crystal Structure Of Human B2-Adren 5e-04
3p0g_A501 Structure Of A Nanobody-Stabilized Active State Of 5e-04
3pds_A458 Irreversible Agonist-Beta2 Adrenoceptor Complex Len 7e-04
>pdb|2Y00|B Chain B, Turkey Beta1 Adrenergic Receptor With Stabilising Mutations And Bound Partial Agonist Dobutamine (Crystal Dob92) Length = 315 Back     alignment and structure

Iteration: 1

Score = 64.7 bits (156), Expect = 1e-10, Method: Compositional matrix adjust. Identities = 61/281 (21%), Positives = 127/281 (45%), Gaps = 28/281 (9%) Query: 57 GNGYMISSVMIEDHLRRRGNTYIAVEALADLLVSGVVIPVSAVMILAGIKQAEPIKEIMC 116 GN +I+++ L+ N +I A ADL+V +V+P A +++ G +C Sbjct: 28 GNVLVIAAIGSTQRLQTLTNLFITSLACADLVVGLLVVPFGATLVVRG---TWLWGSFLC 84 Query: 117 HVQWFLTLLCSLVTVWTLAMIAMENYVRLCMPPECYTFFSKSHIILSVIMIWLVSILLTT 176 + L +LC ++ TL +IA++ Y+ + P + +++ + + +W +S L++ Sbjct: 85 ELWTSLDVLCVTASIETLCVIAIDRYLAITSPFRYQSLMTRARAKVIICTVWAISALVSF 144 Query: 177 LQFIYKVGPDYCSKKVSYMELYQ-------------GIIGSLF-FFIPIIITCILYMKIT 222 L + D + ++ YQ I S+ F+IP++I + +++ Sbjct: 145 LPIMMHWWRD---EDPQALKCYQDPGCCDFVTNRAYAIASSIISFYIPLLIMIFVALRVY 201 Query: 223 YKV-----RLARQNPSFKPPVIFGWDYSLMLTNMYSYIMFIVLWIPFCIVMSVASFRHQI 277 + ++ R + V+ ++ + T +F + W+PF +V V F + Sbjct: 202 REAKEQIRKIDRASKRKTSRVMLMREHKALKTLGIIMGVFTLCWLPFFLVNIVNVFNRDL 261 Query: 278 TPSFYYLA--WLALSKSCINSVLYCISNRHFRNAYINLFHY 316 P + ++A WL + S +N ++YC S FR A+ L + Sbjct: 262 VPDWLFVAFNWLGYANSAMNPIIYCRSP-DFRKAFKRLLAF 301
>pdb|2VT4|A Chain A, Turkey Beta1 Adrenergic Receptor With Stabilising Mutations And Bound Cyanopindolol Length = 313 Back     alignment and structure
>pdb|2X72|A Chain A, Crystal Structure Of The Constitutively Active E113q,N2c, D282c Rhodopsin Mutant With Bound Galphact Peptide Length = 349 Back     alignment and structure
>pdb|3OAX|A Chain A, Crystal Structure Of Bovine Rhodopsin With Beta-Ionone Length = 349 Back     alignment and structure
>pdb|1JFP|A Chain A, Structure Of Bovine Rhodopsin (Dark Adapted) Length = 348 Back     alignment and structure
>pdb|4A4M|A Chain A, Crystal Structure Of The Light-Activated Constitutively Active N2c,M257y,D282c Rhodopsin Mutant In Complex With A Peptide Resembling The C-Terminus Of The Galpha-Protein Subunit (Gact) Length = 349 Back     alignment and structure
>pdb|2J4Y|A Chain A, Crystal Structure Of A Rhodopsin Stabilizing Mutant Expressed In Mammalian Cells Length = 349 Back     alignment and structure
>pdb|3C9M|A Chain A, Structure Of A Mutant Bovine Rhodopsin In Hexagonal Crystal Form Length = 348 Back     alignment and structure
>pdb|4GBR|A Chain A, N-terminal T4 Lysozyme Fusion Facilitates Crystallization Of A G Protein Coupled Receptor Length = 309 Back     alignment and structure
>pdb|3D4S|A Chain A, Cholesterol Bound Form Of Human Beta2 Adrenergic Receptor. Length = 490 Back     alignment and structure
>pdb|3D4S|A Chain A, Cholesterol Bound Form Of Human Beta2 Adrenergic Receptor. Length = 490 Back     alignment and structure
>pdb|3PBL|A Chain A, Structure Of The Human Dopamine D3 Receptor In Complex With Eticlopride Length = 481 Back     alignment and structure
>pdb|4DJH|A Chain A, Structure Of The Human Kappa Opioid Receptor In Complex With Jdtic Length = 480 Back     alignment and structure
>pdb|3SN6|R Chain R, Crystal Structure Of The Beta2 Adrenergic Receptor-Gs Protein Complex Length = 514 Back     alignment and structure
>pdb|3KJ6|A Chain A, Crystal Structure Of A Methylated Beta2 Adrenergic Receptor- Fab Complex Length = 366 Back     alignment and structure
>pdb|2R4R|A Chain A, Crystal Structure Of The Human Beta2 Adrenoceptor Length = 365 Back     alignment and structure
>pdb|2R4S|A Chain A, Crystal Structure Of The Human Beta2 Adrenoceptor Length = 342 Back     alignment and structure
>pdb|2RH1|A Chain A, High Resolution Crystal Structure Of Human B2-Adrenergic G Protein- Coupled Receptor Length = 500 Back     alignment and structure
>pdb|3P0G|A Chain A, Structure Of A Nanobody-Stabilized Active State Of The Beta2 Adrenoceptor Length = 501 Back     alignment and structure
>pdb|3PDS|A Chain A, Irreversible Agonist-Beta2 Adrenoceptor Complex Length = 458 Back     alignment and structure

Structure Templates Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query492
3sn6_R514 Lysozyme, beta-2 adrenergic receptor; seven transm 4e-27
3sn6_R 514 Lysozyme, beta-2 adrenergic receptor; seven transm 1e-07
4amj_A315 Beta-1 adrenergic receptor; membrane protein, 7TMR 9e-26
4amj_A 315 Beta-1 adrenergic receptor; membrane protein, 7TMR 2e-06
1u19_A349 Rhodopsin; G protein-coupled receptor, membrane pr 1e-22
1u19_A 349 Rhodopsin; G protein-coupled receptor, membrane pr 5e-06
2z73_A448 Rhodopsin; visual pigment, GQ-type, G-protein coup 2e-22
2z73_A 448 Rhodopsin; visual pigment, GQ-type, G-protein coup 5e-06
2ks9_A364 Substance-P receptor; water, autodock, NK1, neurop 3e-21
2ks9_A 364 Substance-P receptor; water, autodock, NK1, neurop 1e-04
4ea3_A434 Fusion protein of nociceptin receptor and cytochr; 6e-20
3eml_A488 Human adenosine A2A receptor/T4 lysozyme chimera; 4e-16
3eml_A488 Human adenosine A2A receptor/T4 lysozyme chimera; 7e-07
3eml_A 488 Human adenosine A2A receptor/T4 lysozyme chimera; 2e-06
3pbl_A481 D(3) dopamine receptor, lysozyme chimera; structur 5e-15
3pbl_A481 D(3) dopamine receptor, lysozyme chimera; structur 8e-07
3pbl_A 481 D(3) dopamine receptor, lysozyme chimera; structur 9e-06
2rh1_A500 Beta-2-adrenergic receptor/T4-lysozyme chimera; GP 7e-15
2rh1_A500 Beta-2-adrenergic receptor/T4-lysozyme chimera; GP 3e-06
2rh1_A 500 Beta-2-adrenergic receptor/T4-lysozyme chimera; GP 3e-05
3uon_A467 Human M2 muscarinic acetylcholine, receptor T4 LY 1e-14
3uon_A467 Human M2 muscarinic acetylcholine, receptor T4 LY 2e-06
3uon_A 467 Human M2 muscarinic acetylcholine, receptor T4 LY 3e-05
4eiy_A447 Adenosine receptor A2A/soluble cytochrome B562 CH; 2e-14
4eiy_A447 Adenosine receptor A2A/soluble cytochrome B562 CH; 2e-07
4eiy_A 447 Adenosine receptor A2A/soluble cytochrome B562 CH; 2e-05
3rze_A452 Histamine H1 receptor, lysozyme chimera; structura 8e-14
3rze_A452 Histamine H1 receptor, lysozyme chimera; structura 2e-06
3rze_A 452 Histamine H1 receptor, lysozyme chimera; structura 9e-05
3v2y_A520 Sphingosine 1-phosphate receptor 1, lysozyme CHIM; 4e-12
3v2y_A520 Sphingosine 1-phosphate receptor 1, lysozyme CHIM; 1e-06
3v2y_A 520 Sphingosine 1-phosphate receptor 1, lysozyme CHIM; 2e-04
3odu_A502 C-X-C chemokine receptor type 4, lysozyme chimera; 2e-11
4dkl_A464 MU-type opioid receptor, lysozyme chimera; G-prote 5e-08
4dkl_A464 MU-type opioid receptor, lysozyme chimera; G-prote 2e-04
1vt4_I 1221 APAF-1 related killer DARK; drosophila apoptosome, 2e-07
>3sn6_R Lysozyme, beta-2 adrenergic receptor; seven transmembrane receptor, nanobody, G protein-coupled RE GPCR, signal transduction, G protein signaling; HET: P0G; 3.20A {Enterobacteria phage T4} PDB: 3kj6_A 2r4s_A 2r4r_A Length = 514 Back     alignment and structure
 Score =  113 bits (283), Expect = 4e-27
 Identities = 63/374 (16%), Positives = 136/374 (36%), Gaps = 47/374 (12%)

Query: 3   TPDFSSNNSLFPFTTELLTSATPMDTVDPSTLPYDWNRVARLLITTGLSVLGSVGNGYMI 62
               S   +  P   + + +     T D       W  V   ++ + + +    GN  +I
Sbjct: 146 NLAKSRWYNQTPNRAKRVITTFRTGTWDAYAADEVW-VVGMGIVMSLIVLAIVFGNVLVI 204

Query: 63  SSVMIEDHLRRRGNTYIAVEALADLLVSGVVIPVSAVMILAGIKQAEPIKEIMCHVQWFL 122
           +++   + L+   N +I   A ADL++   V+P  A  IL             C     +
Sbjct: 205 TAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILTKT---WTFGNFWCEFWTSI 261

Query: 123 TLLCSLVTVWTLAMIAMENYVRLCMPPECYTFFSKSHIILSVIMIWLVSILLTTLQFIYK 182
            +LC   ++ TL +IA++ Y  +  P +  +  +K+   + ++M+W+VS L + L     
Sbjct: 262 DVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMH 321

Query: 183 VGPDYCSKKVS----------YMELYQGIIGSLF-FFIPIIITCILYMKITYKV--RLAR 229
                  + ++          +      I  S+  F++P++I   +Y ++ ++   R  +
Sbjct: 322 WYRATHQEAINCYAEETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRV-FQEAKRQLQ 380

Query: 230 QNPSFKPPVIFGWDYSLMLTNMYSYIM-----------------------FIVLWIPFCI 266
           +    +          +       + +                       F + W+PF I
Sbjct: 381 KIDKSEGRFHVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFI 440

Query: 267 VMSVASFRHQITPS--FYYLAWLALSKSCINSVLYCISNRHFRNAYINLFHYCCCKTTVT 324
           V  V   +  +     +  L W+    S  N ++YC  +  FR A+  L    C + +  
Sbjct: 441 VNIVHVIQDNLIRKEVYILLNWIGYVNSGFNPLIYC-RSPDFRIAFQELL---CLRRSSL 496

Query: 325 FSRRSRGDATRPSG 338
            +  +   +   +G
Sbjct: 497 KAYGNGYSSNGNTG 510


>3sn6_R Lysozyme, beta-2 adrenergic receptor; seven transmembrane receptor, nanobody, G protein-coupled RE GPCR, signal transduction, G protein signaling; HET: P0G; 3.20A {Enterobacteria phage T4} PDB: 3kj6_A 2r4s_A 2r4r_A Length = 514 Back     alignment and structure
>4amj_A Beta-1 adrenergic receptor; membrane protein, 7TMR BETA1-adrenoceptor, stabilising mutat biased agonist; HET: CVD 2CV; 2.30A {Meleagris gallopavo} PDB: 2y01_A* 2y02_A* 2y03_A* 2y04_A* 4ami_A* 2y00_A* 2vt4_A* 2ycw_A* 2ycx_A* 2ycy_A* 2ycz_A* Length = 315 Back     alignment and structure
>4amj_A Beta-1 adrenergic receptor; membrane protein, 7TMR BETA1-adrenoceptor, stabilising mutat biased agonist; HET: CVD 2CV; 2.30A {Meleagris gallopavo} PDB: 2y01_A* 2y02_A* 2y03_A* 2y04_A* 4ami_A* 2y00_A* 2vt4_A* 2ycw_A* 2ycx_A* 2ycy_A* 2ycz_A* Length = 315 Back     alignment and structure
>1u19_A Rhodopsin; G protein-coupled receptor, membrane protein, retinal protei photoreceptor, signaling protein; HET: MAN NAG BMA RET PLM HTO HTG; 2.20A {Bos taurus} SCOP: f.13.1.2 PDB: 1hzx_A* 1gzm_A* 1l9h_A* 2g87_A* 2hpy_A* 2i35_A* 2i36_A* 2i37_A* 2ped_A* 3oax_A* 3c9l_A* 1jfp_A* 1ln6_A* 1f88_A* 3cap_A* 3dqb_A* 3pqr_A* 3pxo_A* 3c9m_A* 2x72_A* ... Length = 349 Back     alignment and structure
>1u19_A Rhodopsin; G protein-coupled receptor, membrane protein, retinal protei photoreceptor, signaling protein; HET: MAN NAG BMA RET PLM HTO HTG; 2.20A {Bos taurus} SCOP: f.13.1.2 PDB: 1hzx_A* 1gzm_A* 1l9h_A* 2g87_A* 2hpy_A* 2i35_A* 2i36_A* 2i37_A* 2ped_A* 3oax_A* 3c9l_A* 1jfp_A* 1ln6_A* 1f88_A* 3cap_A* 3dqb_A* 3pqr_A* 3pxo_A* 3c9m_A* 2x72_A* ... Length = 349 Back     alignment and structure
>2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 Back     alignment and structure
>2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 Back     alignment and structure
>2ks9_A Substance-P receptor; water, autodock, NK1, neuropeptide receptor-NEU complex; NMR {Homo sapiens} PDB: 2ksa_A 2ksb_A Length = 364 Back     alignment and structure
>2ks9_A Substance-P receptor; water, autodock, NK1, neuropeptide receptor-NEU complex; NMR {Homo sapiens} PDB: 2ksa_A 2ksb_A Length = 364 Back     alignment and structure
>3eml_A Human adenosine A2A receptor/T4 lysozyme chimera; caffeine, GPCR, membrane protein, LCP, mesophase, structural genomics, PSI-2; HET: ZMA STE; 2.60A {Homo sapiens} PDB: 3qak_A* Length = 488 Back     alignment and structure
>3eml_A Human adenosine A2A receptor/T4 lysozyme chimera; caffeine, GPCR, membrane protein, LCP, mesophase, structural genomics, PSI-2; HET: ZMA STE; 2.60A {Homo sapiens} PDB: 3qak_A* Length = 488 Back     alignment and structure
>3eml_A Human adenosine A2A receptor/T4 lysozyme chimera; caffeine, GPCR, membrane protein, LCP, mesophase, structural genomics, PSI-2; HET: ZMA STE; 2.60A {Homo sapiens} PDB: 3qak_A* Length = 488 Back     alignment and structure
>3pbl_A D(3) dopamine receptor, lysozyme chimera; structural genomics, PSI-2, protein structure initiative, AC technologies center for gene to 3D structure; HET: ETQ MAL; 2.89A {Homo sapiens} Length = 481 Back     alignment and structure
>3pbl_A D(3) dopamine receptor, lysozyme chimera; structural genomics, PSI-2, protein structure initiative, AC technologies center for gene to 3D structure; HET: ETQ MAL; 2.89A {Homo sapiens} Length = 481 Back     alignment and structure
>3pbl_A D(3) dopamine receptor, lysozyme chimera; structural genomics, PSI-2, protein structure initiative, AC technologies center for gene to 3D structure; HET: ETQ MAL; 2.89A {Homo sapiens} Length = 481 Back     alignment and structure
>2rh1_A Beta-2-adrenergic receptor/T4-lysozyme chimera; GPCR, 7TM, fusion, lipidic cubic phase, lipidic, mesophase, cholesterol, membrane protein; HET: MAL CAU CLR PLM 12P; 2.40A {Homo sapiens} PDB: 3p0g_A* 3d4s_A* 3ny8_A* 3ny9_A* 3nya_A* 3pds_A* Length = 500 Back     alignment and structure
>2rh1_A Beta-2-adrenergic receptor/T4-lysozyme chimera; GPCR, 7TM, fusion, lipidic cubic phase, lipidic, mesophase, cholesterol, membrane protein; HET: MAL CAU CLR PLM 12P; 2.40A {Homo sapiens} PDB: 3p0g_A* 3d4s_A* 3ny8_A* 3ny9_A* 3nya_A* 3pds_A* Length = 500 Back     alignment and structure
>2rh1_A Beta-2-adrenergic receptor/T4-lysozyme chimera; GPCR, 7TM, fusion, lipidic cubic phase, lipidic, mesophase, cholesterol, membrane protein; HET: MAL CAU CLR PLM 12P; 2.40A {Homo sapiens} PDB: 3p0g_A* 3d4s_A* 3ny8_A* 3ny9_A* 3nya_A* 3pds_A* Length = 500 Back     alignment and structure
>3uon_A Human M2 muscarinic acetylcholine, receptor T4 LY fusion protein; G protein-coupled receptor, GPCR, SI protein-antagonist complex; HET: QNB BGC; 3.00A {Homo sapiens} PDB: 4daj_A* Length = 467 Back     alignment and structure
>3uon_A Human M2 muscarinic acetylcholine, receptor T4 LY fusion protein; G protein-coupled receptor, GPCR, SI protein-antagonist complex; HET: QNB BGC; 3.00A {Homo sapiens} PDB: 4daj_A* Length = 467 Back     alignment and structure
>3uon_A Human M2 muscarinic acetylcholine, receptor T4 LY fusion protein; G protein-coupled receptor, GPCR, SI protein-antagonist complex; HET: QNB BGC; 3.00A {Homo sapiens} PDB: 4daj_A* Length = 467 Back     alignment and structure
>4eiy_A Adenosine receptor A2A/soluble cytochrome B562 CH; novel protein engineering, GPCR network, PSI-biology, struct genomics, membrane protein, GPCR; HET: ZMA CLR OLA OLC OLB; 1.80A {Homo sapiens} PDB: 3vg9_A* 3vga_A* 2ydv_A* 2ydo_A* 3uza_A* 3rey_A* 3rfm_A* 3pwh_A* 3uzc_A* 4er9_A Length = 447 Back     alignment and structure
>4eiy_A Adenosine receptor A2A/soluble cytochrome B562 CH; novel protein engineering, GPCR network, PSI-biology, struct genomics, membrane protein, GPCR; HET: ZMA CLR OLA OLC OLB; 1.80A {Homo sapiens} PDB: 3vg9_A* 3vga_A* 2ydv_A* 2ydo_A* 3uza_A* 3rey_A* 3rfm_A* 3pwh_A* 3uzc_A* 4er9_A Length = 447 Back     alignment and structure
>4eiy_A Adenosine receptor A2A/soluble cytochrome B562 CH; novel protein engineering, GPCR network, PSI-biology, struct genomics, membrane protein, GPCR; HET: ZMA CLR OLA OLC OLB; 1.80A {Homo sapiens} PDB: 3vg9_A* 3vga_A* 2ydv_A* 2ydo_A* 3uza_A* 3rey_A* 3rfm_A* 3pwh_A* 3uzc_A* 4er9_A Length = 447 Back     alignment and structure
>3rze_A Histamine H1 receptor, lysozyme chimera; structural genomics, PSI-biology, membrane protein, GPCR NET GPCR, hydrolase; HET: 5EH D7V OLC; 3.10A {Homo sapiens} Length = 452 Back     alignment and structure
>3rze_A Histamine H1 receptor, lysozyme chimera; structural genomics, PSI-biology, membrane protein, GPCR NET GPCR, hydrolase; HET: 5EH D7V OLC; 3.10A {Homo sapiens} Length = 452 Back     alignment and structure
>3rze_A Histamine H1 receptor, lysozyme chimera; structural genomics, PSI-biology, membrane protein, GPCR NET GPCR, hydrolase; HET: 5EH D7V OLC; 3.10A {Homo sapiens} Length = 452 Back     alignment and structure
>3v2y_A Sphingosine 1-phosphate receptor 1, lysozyme CHIM; EDG receptor, lipid receptor, multiple sclerosi autoimmunity, structural genomics, PSI-biology; HET: ML5 NAG; 2.80A {Homo sapiens} PDB: 3v2w_A* Length = 520 Back     alignment and structure
>3v2y_A Sphingosine 1-phosphate receptor 1, lysozyme CHIM; EDG receptor, lipid receptor, multiple sclerosi autoimmunity, structural genomics, PSI-biology; HET: ML5 NAG; 2.80A {Homo sapiens} PDB: 3v2w_A* Length = 520 Back     alignment and structure
>3v2y_A Sphingosine 1-phosphate receptor 1, lysozyme CHIM; EDG receptor, lipid receptor, multiple sclerosi autoimmunity, structural genomics, PSI-biology; HET: ML5 NAG; 2.80A {Homo sapiens} PDB: 3v2w_A* Length = 520 Back     alignment and structure
>3odu_A C-X-C chemokine receptor type 4, lysozyme chimera; structural genomics, PSI-2, protein structure initiative; HET: ITD OLC OLA; 2.50A {Homo sapiens} PDB: 3oe8_A* 3oe6_A* 3oe0_A* 3oe9_A* 2k03_B* 2k04_B 2k05_B* Length = 502 Back     alignment and structure
>4dkl_A MU-type opioid receptor, lysozyme chimera; G-protein coupled receptor, 7 transmembrane receptor, signal protein-antagonist complex; HET: BF0 CLR MPG 1PE; 2.80A {Mus musculus} PDB: 4ej4_A* 4djh_A* Length = 464 Back     alignment and structure
>4dkl_A MU-type opioid receptor, lysozyme chimera; G-protein coupled receptor, 7 transmembrane receptor, signal protein-antagonist complex; HET: BF0 CLR MPG 1PE; 2.80A {Mus musculus} PDB: 4ej4_A* 4djh_A* Length = 464 Back     alignment and structure
>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 Back     alignment and structure

Structure Templates Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query492
4grv_A510 Neurotensin receptor type 1, lysozyme chimera; G-p 100.0
2rh1_A500 Beta-2-adrenergic receptor/T4-lysozyme chimera; GP 100.0
3uon_A467 Human M2 muscarinic acetylcholine, receptor T4 LY 100.0
2ks9_A364 Substance-P receptor; water, autodock, NK1, neurop 100.0
1u19_A349 Rhodopsin; G protein-coupled receptor, membrane pr 100.0
3odu_A502 C-X-C chemokine receptor type 4, lysozyme chimera; 100.0
3rze_A452 Histamine H1 receptor, lysozyme chimera; structura 100.0
3v2y_A520 Sphingosine 1-phosphate receptor 1, lysozyme CHIM; 100.0
3pbl_A481 D(3) dopamine receptor, lysozyme chimera; structur 100.0
3vw7_A484 Proteinase-activated receptor 1, lysozyme; high re 100.0
3eml_A488 Human adenosine A2A receptor/T4 lysozyme chimera; 100.0
4dkl_A464 MU-type opioid receptor, lysozyme chimera; G-prote 100.0
4eiy_A447 Adenosine receptor A2A/soluble cytochrome B562 CH; 100.0
4amj_A315 Beta-1 adrenergic receptor; membrane protein, 7TMR 100.0
4ea3_A434 Fusion protein of nociceptin receptor and cytochr; 100.0
2z73_A448 Rhodopsin; visual pigment, GQ-type, G-protein coup 100.0
2lnl_A296 C-X-C chemokine receptor type 1; G protein coupled 100.0
3sn6_R514 Lysozyme, beta-2 adrenergic receptor; seven transm 100.0
4grv_A 510 Neurotensin receptor type 1, lysozyme chimera; G-p 99.68
2rh1_A 500 Beta-2-adrenergic receptor/T4-lysozyme chimera; GP 99.63
3rze_A 452 Histamine H1 receptor, lysozyme chimera; structura 99.63
4amj_A 315 Beta-1 adrenergic receptor; membrane protein, 7TMR 99.62
3uon_A 467 Human M2 muscarinic acetylcholine, receptor T4 LY 99.61
3vw7_A 484 Proteinase-activated receptor 1, lysozyme; high re 99.6
2lnl_A 296 C-X-C chemokine receptor type 1; G protein coupled 99.59
4dkl_A 464 MU-type opioid receptor, lysozyme chimera; G-prote 99.59
1u19_A 349 Rhodopsin; G protein-coupled receptor, membrane pr 99.59
2ks9_A 364 Substance-P receptor; water, autodock, NK1, neurop 99.58
3v2y_A 520 Sphingosine 1-phosphate receptor 1, lysozyme CHIM; 99.57
3pbl_A 481 D(3) dopamine receptor, lysozyme chimera; structur 99.57
4ea3_A 434 Fusion protein of nociceptin receptor and cytochr; 99.56
3eml_A 488 Human adenosine A2A receptor/T4 lysozyme chimera; 99.56
3sn6_R 514 Lysozyme, beta-2 adrenergic receptor; seven transm 99.56
3odu_A 502 C-X-C chemokine receptor type 4, lysozyme chimera; 99.55
4eiy_A 447 Adenosine receptor A2A/soluble cytochrome B562 CH; 99.54
2z73_A 448 Rhodopsin; visual pigment, GQ-type, G-protein coup 99.53
1hll_A32 Alpha-2A adrenergic receptor; helix-linker-helix, 98.57
2koe_A40 Human cannabinoid receptor 1 - helix 7/8 peptide; 98.45
1hll_A32 Alpha-2A adrenergic receptor; helix-linker-helix, 98.37
2ki9_A33 Cannabinoid receptor 2; GPCR, G-protein coupled re 97.31
2lot_A64 Apelin receptor; membrane protein; NMR {Homo sapie 94.73
>4grv_A Neurotensin receptor type 1, lysozyme chimera; G-protein coupled receptor, G-protein, signaling protein-agonist complex; HET: EPE; 2.80A {Rattus norvegicus} Back     alignment and structure
Probab=100.00  E-value=1e-44  Score=372.76  Aligned_cols=282  Identities=21%  Similarity=0.292  Sum_probs=221.7

Q ss_pred             CcchHHHHHHHHHHHHHHHHhhhcceeeeeeeeccccc---cchhhHHHHHHHHHHHhhhchhcHHHHHHHhcCCCcccc
Q psy11022         35 PYDWNRVARLLITTGLSVLGSVGNGYMISSVMIEDHLR---RRGNTYIAVEALADLLVSGVVIPVSAVMILAGIKQAEPI  111 (492)
Q Consensus        35 ~~~~~~~~~~~~~~~~~i~gl~gN~~vi~~i~~~~~lr---~~~~~~l~~Lai~Dll~~~~~~p~~~~~~~~~~~~~~~~  111 (492)
                      .+.+..++..+++.+++++|++||+++++++.++|++|   +++|+|++|||++|++.+++.+|+.+....... ..|.+
T Consensus        27 ~~~~~~v~~~~~~~~i~~~g~~gN~lvi~~i~~~~~~r~~~~~~n~~i~~La~aDll~~~~~~p~~~~~~~~~~-~~w~~  105 (510)
T 4grv_A           27 TDIYSKVLVTAIYLALFVVGTVGNSVTLFTLARKKSLQSLQSTVHYHLGSLALSDLLILLLAMPVELYNFIWVH-HPWAF  105 (510)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHHHHHHHHHTSCC----CCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTTCC-SSCSS
T ss_pred             hhHHHHHHHHHHHHHHHHHHHHHHHHhhhheeeecCCCCCCChHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhC-CCEEh
Confidence            34566788889999999999999999999998877655   678999999999999999899999887655432 25999


Q ss_pred             ccccchhhHHHHHHHHHHHHHHHHHHHHHHHHHHhcCcccccccchhhHHhHhhHHHHHHHHHhhhhhhhcc--------
Q psy11022        112 KEIMCHVQWFLTLLCSLVTVWTLAMIAMENYVRLCMPPECYTFFSKSHIILSVIMIWLVSILLTTLQFIYKV--------  183 (492)
Q Consensus       112 ~~~~C~~~~~~~~~~~~~s~~~l~~ia~dRy~aI~~P~~~~~~~t~~~~~~~i~~~w~~s~~~~~~~~~~~~--------  183 (492)
                      |+.+|++..++...+..+|++++++||+|||+||++|++|+..++++++..+++++|++++++++|+++...        
T Consensus       106 g~~~C~~~~~~~~~~~~~S~~~l~~is~dRy~ai~~P~~~~~~~t~~~~~~~i~~~W~~s~~~~~p~~~~~~~~~~~~~~  185 (510)
T 4grv_A          106 GDAGCRGYYFLRDACTYATALNVASLSVARYLAICHPFKAKTLMSRSRTKKFISAIWLASALLAIPMLFTMGLQNRSADG  185 (510)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHSCCCCCCCCCCSCCHHHHHHHHHHHHHHHTTHHHHEEEEECSSSS
T ss_pred             hHHHHHHHHHHHHHHHHHHHHHHHHHHHHheEEEeccccccccccccccceeehHHHHHHHHHHHHHHHhhcccccccCC
Confidence            999999999999999999999999999999999999999999999999999999999999999999886421        


Q ss_pred             ---ccccccccccc--chhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhcC---------------------------
Q psy11022        184 ---GPDYCSKKVSY--MELYQGIIGSLFFFIPIIITCILYMKITYKVRLARQN---------------------------  231 (492)
Q Consensus       184 ---~~~~C~~~~~~--~~~~~~~~~~~~~~ip~~ii~~~y~~i~~~l~~~~~~---------------------------  231 (492)
                         ....|...++.  ...+..+..++.+++|+++++++|.+|+++++++.+.                           
T Consensus       186 ~~~~~~~c~~~~~~~~~~~~~~~~~~~~f~iP~~ii~~~Y~~I~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (510)
T 4grv_A          186 THPGGLVCTPIVDTATVKVVIQVNTFMSFLFPMLVISILNTVIANKLTVMVNIFEMLRIDEGLRLKIYKDTEGYYTIGIG  265 (510)
T ss_dssp             CCGGGEEEEECSCHHHHHHHHHHHHHHHTHHHHHHHHHHHHHHHHHHHTSCTHHHHHHHHTCCEEEEEECTTSCEEEETT
T ss_pred             CCCCccccccccccchhhhhhhhhhhHHHhhhHHHHHHHHHHHHHHHHHHhhhhhhhccccccccccccccccccccccc
Confidence               11235544432  3455666667889999999999999999999753210                           


Q ss_pred             --------------------------------------------------------------------------------
Q psy11022        232 --------------------------------------------------------------------------------  231 (492)
Q Consensus       232 --------------------------------------------------------------------------------  231 (492)
                                                                                                      
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  345 (510)
T 4grv_A          266 HLLTKSPSLNAAKSELDKAIGRNTNGVITKDEAEKLFNQDVDAAVRGILRNAKLKPVYDSLDAVRRAALINMVFQMGETG  345 (510)
T ss_dssp             EECCCSSSHHHHHHSCCC---CCCTTBCCHHHHHHHHHHHHHHHHHHHHHCTTTHHHHHHSCSHHHHHHHHHHHHHHHHH
T ss_pred             cccCCCCCCCccccccCcCCCCCCCCcccCCccccccCCCCcccccccccCCCCCCCcCccccccccccCCccccCCCCC
Confidence                                                                                            


Q ss_pred             -----------------------------------------------CCCCCCcccchhhHHHHHHHHHHHHHHHHhHhH
Q psy11022        232 -----------------------------------------------PSFKPPVIFGWDYSLMLTNMYSYIMFIVLWIPF  264 (492)
Q Consensus       232 -----------------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~f~i~~~P~  264 (492)
                                                                     .+.+..+..++|+|++|++++++++|++||+|+
T Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~erk~~k~L~iVv~~F~iCWlPf  425 (510)
T 4grv_A          346 VAGFTNSLRMLNNKRWDEAAVNLAKSRWYNQTPNRAKRVITTFRTGTWDAYGSGSVQALRHGVLVARAVVIAFVVCWLPY  425 (510)
T ss_dssp             HTTCHHHHHHHTTTCHHHHHHHHHSSCSCCSSHHHHHHHHHHHHHSSSGGGTTSTTTHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCCCccccccccCCCcccccccccccccccCCccccccccccccccchhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence                                                           000111223567899999999999999999999


Q ss_pred             HHHHHHHhccCCc----------chHHHHHHHHHhhcccccchhhhhcChHHHHHHHHHhccc
Q psy11022        265 CIVMSVASFRHQI----------TPSFYYLAWLALSKSCINSVLYCISNRHFRNAYINLFHYC  317 (492)
Q Consensus       265 ~i~~~~~~~~~~~----------~~~~~~~~~l~~~~s~~nP~IY~~~~~~~R~~~~~~~~~~  317 (492)
                      .+..++..+.+..          .....+..||.|+||++||+||+++|++||++++++++++
T Consensus       426 ~i~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~L~Y~NS~iNPiIY~~~n~~FR~aFk~iL~C~  488 (510)
T 4grv_A          426 HVRRLMFCYISDEQWTTFLFDFYHYFYMLTNALAYASSAINPILYNLVSANFRQVFLSTLACL  488 (510)
T ss_dssp             HHHHHHHHTTTTTCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHSCCCCC--------
T ss_pred             HHHHHHHHHcCcccCChhHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCHHHHHHHHHHHhhc
Confidence            9999887762211          1234456789999999999999999999999999999643



>2rh1_A Beta-2-adrenergic receptor/T4-lysozyme chimera; GPCR, 7TM, fusion, lipidic cubic phase, lipidic, mesophase, cholesterol, membrane protein; HET: MAL CAU CLR PLM 12P; 2.40A {Homo sapiens} PDB: 3p0g_A* 3d4s_A* 3ny8_A* 3ny9_A* 3nya_A* 3pds_A* Back     alignment and structure
>3uon_A Human M2 muscarinic acetylcholine, receptor T4 LY fusion protein; G protein-coupled receptor, GPCR, SI protein-antagonist complex; HET: QNB BGC; 3.00A {Homo sapiens} PDB: 4daj_A* Back     alignment and structure
>2ks9_A Substance-P receptor; water, autodock, NK1, neuropeptide receptor-NEU complex; NMR {Homo sapiens} PDB: 2ksa_A 2ksb_A Back     alignment and structure
>1u19_A Rhodopsin; G protein-coupled receptor, membrane protein, retinal protei photoreceptor, signaling protein; HET: MAN NAG BMA RET PLM HTO HTG; 2.20A {Bos taurus} SCOP: f.13.1.2 PDB: 1hzx_A* 1gzm_A* 1l9h_A* 2g87_A* 2hpy_A* 2i35_A* 2i36_A* 2i37_A* 2ped_A* 3oax_A* 3c9l_A* 1jfp_A* 1ln6_A* 1f88_A* 3cap_A* 3dqb_A* 3pqr_A* 3pxo_A* 3c9m_A* 2x72_A* ... Back     alignment and structure
>3odu_A C-X-C chemokine receptor type 4, lysozyme chimera; structural genomics, PSI-2, protein structure initiative; HET: ITD OLC OLA; 2.50A {Homo sapiens} PDB: 3oe8_A* 3oe6_A* 3oe0_A* 3oe9_A* 2k03_B* 2k04_B 2k05_B* Back     alignment and structure
>3rze_A Histamine H1 receptor, lysozyme chimera; structural genomics, PSI-biology, membrane protein, GPCR NET GPCR, hydrolase; HET: 5EH D7V OLC; 3.10A {Homo sapiens} Back     alignment and structure
>3v2y_A Sphingosine 1-phosphate receptor 1, lysozyme CHIM; EDG receptor, lipid receptor, multiple sclerosi autoimmunity, structural genomics, PSI-biology; HET: ML5 NAG; 2.80A {Homo sapiens} PDB: 3v2w_A* Back     alignment and structure
>3pbl_A D(3) dopamine receptor, lysozyme chimera; structural genomics, PSI-2, PSI-biology, protein structure initiative; HET: ETQ MAL; 2.89A {Homo sapiens} Back     alignment and structure
>3vw7_A Proteinase-activated receptor 1, lysozyme; high resolution structure, protease-activated receptor 1, in conformation, antagonist vorapaxar; HET: VPX OLC; 2.20A {Homo sapiens} Back     alignment and structure
>3eml_A Human adenosine A2A receptor/T4 lysozyme chimera; caffeine, GPCR, membrane protein, LCP, mesophase, structural genomics, PSI-2; HET: ZMA STE; 2.60A {Homo sapiens} PDB: 3qak_A* Back     alignment and structure
>4dkl_A MU-type opioid receptor, lysozyme chimera; G-protein coupled receptor, 7 transmembrane receptor, signal protein-antagonist complex; HET: BF0 CLR MPG 1PE; 2.80A {Mus musculus} PDB: 4ej4_A* 4djh_A* Back     alignment and structure
>4eiy_A Adenosine receptor A2A/soluble cytochrome B562 CH; novel protein engineering, GPCR network, PSI-biology, struct genomics, membrane protein, GPCR; HET: ZMA CLR OLA OLC OLB; 1.80A {Homo sapiens} PDB: 3vg9_A* 3vga_A* 2ydv_A* 2ydo_A* 3uza_A* 3rey_A* 3rfm_A* 3pwh_A* 3uzc_A* 4er9_A Back     alignment and structure
>4amj_A Beta-1 adrenergic receptor; membrane protein, 7TMR BETA1-adrenoceptor, stabilising mutat biased agonist; HET: CVD 2CV; 2.30A {Meleagris gallopavo} PDB: 2y01_A* 2y02_A* 2y03_A* 2y04_A* 4ami_A* 2y00_A* 2vt4_A* 2ycw_A* 2ycx_A* 2ycy_A* 2ycz_A* Back     alignment and structure
>2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Back     alignment and structure
>2lnl_A C-X-C chemokine receptor type 1; G protein coupled receptor, GPCR, membrane protei transmembrane, 7TM, phospholipid, signaling, signaling PROT; NMR {Homo sapiens} Back     alignment and structure
>3sn6_R Lysozyme, beta-2 adrenergic receptor; seven transmembrane receptor, nanobody, G protein-coupled RE GPCR, signal transduction, G protein signaling; HET: P0G; 3.20A {Enterobacteria phage T4} PDB: 3kj6_A 2r4s_A 2r4r_A 4gbr_A* Back     alignment and structure
>4grv_A Neurotensin receptor type 1, lysozyme chimera; G-protein coupled receptor, G-protein, signaling protein-agonist complex; HET: EPE; 2.80A {Rattus norvegicus} Back     alignment and structure
>2rh1_A Beta-2-adrenergic receptor/T4-lysozyme chimera; GPCR, 7TM, fusion, lipidic cubic phase, lipidic, mesophase, cholesterol, membrane protein; HET: MAL CAU CLR PLM 12P; 2.40A {Homo sapiens} PDB: 3p0g_A* 3d4s_A* 3ny8_A* 3ny9_A* 3nya_A* 3pds_A* Back     alignment and structure
>3rze_A Histamine H1 receptor, lysozyme chimera; structural genomics, PSI-biology, membrane protein, GPCR NET GPCR, hydrolase; HET: 5EH D7V OLC; 3.10A {Homo sapiens} Back     alignment and structure
>4amj_A Beta-1 adrenergic receptor; membrane protein, 7TMR BETA1-adrenoceptor, stabilising mutat biased agonist; HET: CVD 2CV; 2.30A {Meleagris gallopavo} PDB: 2y01_A* 2y02_A* 2y03_A* 2y04_A* 4ami_A* 2y00_A* 2vt4_A* 2ycw_A* 2ycx_A* 2ycy_A* 2ycz_A* Back     alignment and structure
>3uon_A Human M2 muscarinic acetylcholine, receptor T4 LY fusion protein; G protein-coupled receptor, GPCR, SI protein-antagonist complex; HET: QNB BGC; 3.00A {Homo sapiens} PDB: 4daj_A* Back     alignment and structure
>3vw7_A Proteinase-activated receptor 1, lysozyme; high resolution structure, protease-activated receptor 1, in conformation, antagonist vorapaxar; HET: VPX OLC; 2.20A {Homo sapiens} Back     alignment and structure
>2lnl_A C-X-C chemokine receptor type 1; G protein coupled receptor, GPCR, membrane protei transmembrane, 7TM, phospholipid, signaling, signaling PROT; NMR {Homo sapiens} Back     alignment and structure
>4dkl_A MU-type opioid receptor, lysozyme chimera; G-protein coupled receptor, 7 transmembrane receptor, signal protein-antagonist complex; HET: BF0 CLR MPG 1PE; 2.80A {Mus musculus} PDB: 4ej4_A* 4djh_A* Back     alignment and structure
>1u19_A Rhodopsin; G protein-coupled receptor, membrane protein, retinal protei photoreceptor, signaling protein; HET: MAN NAG BMA RET PLM HTO HTG; 2.20A {Bos taurus} SCOP: f.13.1.2 PDB: 1hzx_A* 1gzm_A* 1l9h_A* 2g87_A* 2hpy_A* 2i35_A* 2i36_A* 2i37_A* 2ped_A* 3oax_A* 3c9l_A* 1jfp_A* 1ln6_A* 1f88_A* 3cap_A* 3dqb_A* 3pqr_A* 3pxo_A* 3c9m_A* 2x72_A* ... Back     alignment and structure
>2ks9_A Substance-P receptor; water, autodock, NK1, neuropeptide receptor-NEU complex; NMR {Homo sapiens} PDB: 2ksa_A 2ksb_A Back     alignment and structure
>3v2y_A Sphingosine 1-phosphate receptor 1, lysozyme CHIM; EDG receptor, lipid receptor, multiple sclerosi autoimmunity, structural genomics, PSI-biology; HET: ML5 NAG; 2.80A {Homo sapiens} PDB: 3v2w_A* Back     alignment and structure
>3pbl_A D(3) dopamine receptor, lysozyme chimera; structural genomics, PSI-2, PSI-biology, protein structure initiative; HET: ETQ MAL; 2.89A {Homo sapiens} Back     alignment and structure
>3eml_A Human adenosine A2A receptor/T4 lysozyme chimera; caffeine, GPCR, membrane protein, LCP, mesophase, structural genomics, PSI-2; HET: ZMA STE; 2.60A {Homo sapiens} PDB: 3qak_A* Back     alignment and structure
>3sn6_R Lysozyme, beta-2 adrenergic receptor; seven transmembrane receptor, nanobody, G protein-coupled RE GPCR, signal transduction, G protein signaling; HET: P0G; 3.20A {Enterobacteria phage T4} PDB: 3kj6_A 2r4s_A 2r4r_A 4gbr_A* Back     alignment and structure
>3odu_A C-X-C chemokine receptor type 4, lysozyme chimera; structural genomics, PSI-2, protein structure initiative; HET: ITD OLC OLA; 2.50A {Homo sapiens} PDB: 3oe8_A* 3oe6_A* 3oe0_A* 3oe9_A* 2k03_B* 2k04_B 2k05_B* Back     alignment and structure
>4eiy_A Adenosine receptor A2A/soluble cytochrome B562 CH; novel protein engineering, GPCR network, PSI-biology, struct genomics, membrane protein, GPCR; HET: ZMA CLR OLA OLC OLB; 1.80A {Homo sapiens} PDB: 3vg9_A* 3vga_A* 2ydv_A* 2ydo_A* 3uza_A* 3rey_A* 3rfm_A* 3pwh_A* 3uzc_A* 4er9_A Back     alignment and structure
>2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Back     alignment and structure
>1hll_A Alpha-2A adrenergic receptor; helix-linker-helix, membrane protein; NMR {Synthetic} SCOP: j.94.1.1 PDB: 1hof_A 1ho9_A 1hod_A Back     alignment and structure
>2koe_A Human cannabinoid receptor 1 - helix 7/8 peptide; GPCR, HCB1, membrane protein, signaling protein; NMR {Homo sapiens} Back     alignment and structure
>1hll_A Alpha-2A adrenergic receptor; helix-linker-helix, membrane protein; NMR {Synthetic} SCOP: j.94.1.1 PDB: 1hof_A 1ho9_A 1hod_A Back     alignment and structure
>2ki9_A Cannabinoid receptor 2; GPCR, G-protein coupled receptor, membrane protein; NMR {Synthetic} Back     alignment and structure
>2lot_A Apelin receptor; membrane protein; NMR {Homo sapiens} PDB: 2lou_A 2lov_A 2low_A Back     alignment and structure

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query 492
d1u19a_348 f.13.1.2 (A:) Rhodopsin {Cow (Bos taurus) [TaxId: 9e-13
>d1u19a_ f.13.1.2 (A:) Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} Length = 348 Back     information, alignment and structure

class: Membrane and cell surface proteins and peptides
fold: Family A G protein-coupled receptor-like
superfamily: Family A G protein-coupled receptor-like
family: Rhodopsin-like
domain: Rhodopsin
species: Cow (Bos taurus) [TaxId: 9913]
 Score = 67.3 bits (163), Expect = 9e-13
 Identities = 49/292 (16%), Positives = 95/292 (32%), Gaps = 14/292 (4%)

Query: 50  LSVLGSVGNGYMISSVMIEDHLRRRGNTYIAVEALADLLVSGVVIPVSAVMILAGIKQAE 109
           L +LG   N   +   +    LR   N  +   A+ADL +       +    L G     
Sbjct: 47  LIMLGFPINFLTLYVTVQHKKLRTPLNYILLNLAVADLFMVFGGFTTTLYTSLHGYFVFG 106

Query: 110 PIKEIMCHVQWFLTLLCSLVTVWTLAMIAMENYVRLCMPPECYTFFSKSHIILSVIMIWL 169
           P    +      L    +L ++  LA+       +           +   +  + +M   
Sbjct: 107 PTGCNLEGFFATLGGEIALWSLVVLAIERYVVVCKPMSNFRFGENHAIMGVAFTWVMALA 166

Query: 170 VSILLTTLQFIYKVGPDYCSKKVSYM--------ELYQGIIGSLFFFIPIIITCILYMKI 221
            +         Y      CS  + Y         E +   +  + F IP+I+    Y ++
Sbjct: 167 CAAPPLVGWSRYIPEGMQCSCGIDYYTPHEETNNESFVIYMFVVHFIIPLIVIFFCYGQL 226

Query: 222 TYKVRLARQNPSFKPPVIFGWDYSLMLTNMYSYIMFIVLWIPFCIVMSVASFRHQITPSF 281
            + V+ A      +       +  +    +   I F++ W+P+  V              
Sbjct: 227 VFTVKEAAAQQ-QESATTQKAEKEVTRMVIIMVIAFLICWLPYAGVAFYIFTHQGSDFGP 285

Query: 282 YYL---AWLALSKSCINSVLYCISNRHFRNAYINLFHYCCCKTTVTFSRRSR 330
            ++   A+ A + +  N V+Y + N+ FRN  +     CC K  +     S 
Sbjct: 286 IFMTIPAFFAKTSAVYNPVIYIMMNKQFRNCMVTTL--CCGKNPLGDDEAST 335


Homologous Domains Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query492
d1u19a_348 Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} 100.0
d1u19a_ 348 Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} 99.28
>d1u19a_ f.13.1.2 (A:) Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} Back     information, alignment and structure
class: Membrane and cell surface proteins and peptides
fold: Family A G protein-coupled receptor-like
superfamily: Family A G protein-coupled receptor-like
family: Rhodopsin-like
domain: Rhodopsin
species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00  E-value=7.2e-38  Score=303.71  Aligned_cols=307  Identities=18%  Similarity=0.234  Sum_probs=238.5

Q ss_pred             CCCCCCCccccccccccCCCCCCCCCCCCCCCCCcchHHHHHHHHHHHHHHHHhhhcceeeeeeeeccccccchhhHHHH
Q psy11022          2 MTPDFSSNNSLFPFTTELLTSATPMDTVDPSTLPYDWNRVARLLITTGLSVLGSVGNGYMISSVMIEDHLRRRGNTYIAV   81 (492)
Q Consensus         2 m~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~gl~gN~~vi~~i~~~~~lr~~~~~~l~~   81 (492)
                      |+++++.+..++..+.+...  ....+.......+++...+.+.++.+++++|++||+++++++.++|++|++.|++++|
T Consensus         1 ~~~~~~~~~~~~~~n~t~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ii~v~gi~gN~lvi~vi~~~k~lr~~~~~~l~n   78 (348)
T d1u19a_           1 MNGTEGPNFYVPFSNKTGVV--RSPFEAPQYYLAEPWQFSMLAAYMFLLIMLGFPINFLTLYVTVQHKKLRTPLNYILLN   78 (348)
T ss_dssp             CCSEECSSCEESSCCTTSCC--CCTTTSCCTTTSCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHSTTCCSHHHHHHHH
T ss_pred             CCCCCCCCccccCCCCCCCc--CCCCCCCccccccHHHHHHHHHHHHHHHHHHHHHHHHeehhhhccCCCCCHhHHHHHH
Confidence            55555666554333322222  2222223334455666778889999999999999999999999999999999999999


Q ss_pred             HHHHHHHhhhchhcHHHHHHHhcCCCccccccccchhhHHHHHHHHHHHHHHHHHHHHHHHHHHhcCcccccccchhhHH
Q psy11022         82 EALADLLVSGVVIPVSAVMILAGIKQAEPIKEIMCHVQWFLTLLCSLVTVWTLAMIAMENYVRLCMPPECYTFFSKSHII  161 (492)
Q Consensus        82 Lai~Dll~~~~~~p~~~~~~~~~~~~~~~~~~~~C~~~~~~~~~~~~~s~~~l~~ia~dRy~aI~~P~~~~~~~t~~~~~  161 (492)
                      ||++|++.++...|..+.....+.   |..++..|+...+....+..++.++++++++|||++|++|++|... ++++..
T Consensus        79 LaiaDll~~~~~~~~~~~~~~~~~---~~~~~~~c~~~~~~~~~~~~~s~~~l~~is~~R~~~i~~p~~~~~~-~~~~~~  154 (348)
T d1u19a_          79 LAVADLFMVFGGFTTTLYTSLHGY---FVFGPTGCNLEGFFATLGGEIALWSLVVLAIERYVVVCKPMSNFRF-GENHAI  154 (348)
T ss_dssp             HHHHHHHHHHHTHHHHHHHHHHTS---CTTHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTCCSSSCCC-CHHHHH
T ss_pred             HHHHHHHHHHHHHHHhhhhhccCc---cccCchhhhhhhhccccceeeecchhhhhhcccceeeecccccccc-cccccc
Confidence            999999999888998887776663   6788899999999999999999999999999999999999887664 666777


Q ss_pred             hHhhHHHHHHHHHhhhhhhhcc------cccccccc------cccchhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhh
Q psy11022        162 LSVIMIWLVSILLTTLQFIYKV------GPDYCSKK------VSYMELYQGIIGSLFFFIPIIITCILYMKITYKVRLAR  229 (492)
Q Consensus       162 ~~i~~~w~~s~~~~~~~~~~~~------~~~~C~~~------~~~~~~~~~~~~~~~~~ip~~ii~~~y~~i~~~l~~~~  229 (492)
                      ..++.+|..++++..++.....      ....|...      ......+......+..++|++++.++|.++.+++||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~i~~~~y~~i~~~~~~~~  234 (348)
T d1u19a_         155 MGVAFTWVMALACAAPPLVGWSRYIPEGMQCSCGIDYYTPHEETNNESFVIYMFVVHFIIPLIVIFFCYGQLVFTVKEAA  234 (348)
T ss_dssp             HHHHHHHHHHHHHHSGGGTTSSCCEEETTTTEEECCCSCCCGGGTHHHHHHHHHHHTTHHHHHHHHHHHTTTTTSSCSCC
T ss_pred             ccceeeehhhhheecccccccceeccCCcccccccccccccccccchhhHHHHHHHHHHHHHHHHHHHHHHHHhhhcccc
Confidence            7778888888888877765421      12223322      12234455666667789999999999999988887765


Q ss_pred             cCCCCCCCcccchhhHHHHHHHHHHHHHHHHhHhHHHHHHHHhc---cCCcchHHHHHHHHHhhcccccchhhhhcChHH
Q psy11022        230 QNPSFKPPVIFGWDYSLMLTNMYSYIMFIVLWIPFCIVMSVASF---RHQITPSFYYLAWLALSKSCINSVLYCISNRHF  306 (492)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~f~i~~~P~~i~~~~~~~---~~~~~~~~~~~~~l~~~~s~~nP~IY~~~~~~~  306 (492)
                      ++ +++..++.++|+|.+|+++.++++|++||+|+.+..++...   .+.......+..++.++|+++||+||+++|++|
T Consensus       235 ~~-~~~~~~~~~~~~~~~~~~~~i~~~f~~~~~P~~i~~~~~~~~~~~~~~~~~~~~~~~l~~~ns~iNPiIY~~~~~~f  313 (348)
T d1u19a_         235 AQ-QQESATTQKAEKEVTRMVIIMVIAFLICWLPYAGVAFYIFTHQGSDFGPIFMTIPAFFAKTSAVYNPVIYIMMNKQF  313 (348)
T ss_dssp             CS-SCSSSHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTTSCCCHHHHHHHHHHGGGGGTHHHHHHHHTCHHH
T ss_pred             cc-cchhhhhHHHHhhHhheEEEeehHHHHHhhHHHhhhheeeccCCccccHHHHHHHHHHHHHHHHHHHHHHHhcCHHH
Confidence            43 33444556778999999999999999999999988876655   223344566677889999999999999999999


Q ss_pred             HHHHHHHhc
Q psy11022        307 RNAYINLFH  315 (492)
Q Consensus       307 R~~~~~~~~  315 (492)
                      |++++++++
T Consensus       314 R~~~~~~l~  322 (348)
T d1u19a_         314 RNCMVTTLC  322 (348)
T ss_dssp             HHHHHHHHT
T ss_pred             HHHHHHHhC
Confidence            999999984



>d1u19a_ f.13.1.2 (A:) Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} Back     information, alignment and structure